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1. LIST OF ACRONYMS 
 
ARMS  at-risk mental health state 
BLIPS  brief limited intermittent psychotic symptoms 
CAPE  Community Assessment of Psychic Experiences 
CEN  central executive network  
CHR  clinical high-risk 
DLPFC dorosolateral prefrontal cortex 
DMN  default mode network 
GABA  γ-aminobutyric acid  
GMV  grey matter volume 
IQ  intelligence quotient 
MDD  major depressive disorder 
MTL   medial temporal lobe 
NMDAR N-methyl-D-aspartate receptor 
PLE  psychotic-like experiences 
PQ-16  Prodromal Questionnaire (16-item version)  
PRS  polygenic risk score 
ROI  region of interest 
SBM  surface-based morphometry 
SN  salience network  
STG  superior temporal gyrus 
UHR  ultra-high risk 
VBM  voxel-based morphometry 




1.1. Concept of a continuous spectrum of psychosis phenotypes 
The formulation of psychotic illness developed  during the 19th and 20th centuries (Berrios 
& Beer, 1994; Franzek & Musalek, 2009). Kraepelin’s nosology of the major psychotic 
disorders has shaped clinical practice, seeing a continuation of his model’s relevance to 
contemporary practice (Angst & Gamma, 2008). Later Eysenck’s theory of personality 
recognised psychoticism as a trait dimension of its own (Eysenck, 1952), reflecting the 
notion of a continuous distribution of natural phenotypic variations with psychotic illness 
representing the extreme end (Grant, Green, & Mason, 2018). Although categorical 
models included increasingly diverse observations of psychotic phenotypes over time 
(Angst, 2002; Beer, 1996), efforts to deconstruct psychotic (Gaebel & Zielasek, 2008), 
and psychiatric diagnoses in general (Insel et al., 2010), still prevail today. Psychosis 
phenotypes show variable stability (fluctuating states and enduring traits) and severity 
over time. Early psychosis detection by clinician assessment (e.g., McGlashan et al., 
2010; Yung et al., 2005) aims to capture variations in state and trait phenotypes, which 
still require characterisation based on biological and ultimately aetiological 
underpinnings. For instance, some transient psychosis risk syndromes, e.g., brief limited 
intermittent psychotic symptoms (BLIPS) describe peak psychotic states of short 
duration (relative to frank psychosis) (Schultze-Lutter et al., 2015), while schizotypy is an 
arrangement of personality traits that may decompensate into psychosis under given 
circumstances (Kwapil & Barrantes-vidal, 2015; Nelson, Seal, Pantelis, & Phillips, 2013).
  
The psychopathological phenomena defining psychotic states include positive 
(hallucinations and delusions), negative, and disorganised features (American 
Psychiatric Association, 2013). In the clinical spectrum, phenotype heterogeneity has 
ushered increased attention to expressions of symptom dimensions (Barch et al., 2013). 
Evidence for differential relations between symptom dimensions and clinical outcomes 
(Fulford et al., 2013; Woodward et al., 2014) support the assumption that they may 
constitute independent risk factors producing additive illness effects (Allardyce, Suppes, 
& van Os, 2007). In a comparison between psychosis diagnostic groups, symptom 
dimensions significantly explained clinical characteristics beyond diagnosis alone 
(Dikeos et al., 2006), and genetic overlap between diagnoses of psychotic disorders 
among family lineages suggests common underlying disease mechanisms (Tamminga 
et al., 2013).   
There is ample evidence suggesting that positive, negative, disorganised, and affective 
symptoms prevail in the general population (e.g., Stefanis et al., 2002). Experiences from 
the positive symptom dimension, such as auditory verbal hallucinations (Baumeister, 
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Sedgwick, Howes, & Peters, 2017), and paranoid ideation (Bebbington et al., 2013) are 
found in healthy individuals. These findings suggest that different dimensions of 
psychosis phenotypes do not pertain to clinical thresholds, as they are not associated 
with a need for care. Thus, dimensional psychotic phenomena are not restricted to 
distinctive illness categories, allowing these phenotypes to exists on a spectrum from 
health to illness (Guloksuz & van Os, 2018) and across psychopathological diagnoses 
(Reininghaus et al., 2019). This assumption permits investigations of psychosis 
phenotypes and their aetiology outside of clinical entities.   
The continuum hypothesis of psychosis proposes a continuous distribution of latent 
psychotic phenotypes in the general population (Johns & van Os, 2001; Verdoux & van 
Os, 2002). A meta-analysis by Linscott and van Os (2013) suggested a 7.2% prevalence 
of psychotic experiences among nonclinical individuals, and in 20% of cases these 
experiences continue to persist. In 7.4% with baseline psychotic experiences, these were 
associated with a development of need for care i.e., psychotic disorder. The authors 
concluded that the prevalence of psychotic experiences exceeds that of psychotic 
disorders in the general population estimated at ca. 3% (Perälä et al., 2007). Related to 
the elevated expression of subclinical psychotic symptoms, or psychotic-like experiences 
(PLE), is the variability of individual stable traits in the population.  
Schizotypy is a framework that unifies enduring traits and characteristics that convey a 
latent liability for schizophrenia (Barrantes-Vidal, Grant, & Kwapil, 2015; Cohen, Mohr, 
Ettinger, Chan, & Park, 2015; Grant et al., 2018). Models of schizotypy disagree on 
whether schizotypy is mental illness-based (taxonic and quasi-dimensional; Meehl, 
1962) or extends into fully normal (healthy) continuity at the personality level (Claridge & 
Beech, 1995; for an overview see Grant et al., 2018). Regardless, schizotypy is now 
generally considered a suitable endophenotype of schizophrenia liability (Gottesman & 
Gould, 2003; Grant et al., 2013; Lenzenweger, 2006). Hence, schizotypy contributes to 
the contemporary quest for aetiological models of schizophrenia and psychosis 
(Barrantes-Vidal et al., 2015). This aim also ties in with the overall U.S. National Institute 
of Mental Health Research Domain Criteria framework (Barrantes-Vidal et al., 2015; 
Cohen et al., 2015), promoting dimensional approaches in biological psychiatry.   
Other intraindividual attributes that may alter the course of nonclinical psychotic 
phenotypes include (but are not restricted to) cognitive disturbance (Brett, Peters, & 
McGuire, 2015), the persistence of subclinical PLE (van Os, Linscott, Myin-Germeys, 
Delespaul, & Krabbendam, 2009) distress (Hanssen, Bak, Bijl, Vollebergh, & van Os, 
2005), and personality factors (Alminhana, Farias, Claridge, Cloninger, & Moreira-
Almeida, 2017; Barrantes-Vidal, Ros-Morente, & Kwapil, 2009).  These observations 
align with the notion that distinctions between healthy and clinical psychosis phenotypes 
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are related to quantitative rather than qualitative differences in experiences and 
behaviours (Johns & van Os, 2001). Thus, a continuous psychosis spectrum also 
encourages the investigation of mediating and moderating determinants of phenotype 
trajectories without the constraints of qualitative boundaries. Such relationships may help 
to determine predictors of later at-risk mental health states (ARMS). 
1.2. Neurobiological correlates of psychosis phenotypes 
As psychotic phenotypes and symptoms unfold over time, they may do so on a biological 
level, too. Accumulating epidemiological evidence for the psychosis continuum together 
with genetic and neuroimaging investigations of psychosis prone phenotypes emerged 
within the last decades (Taylor, Calkins, & Gur, 2020). The conceptualisation of elevated 
prodromal syndromes has made valuable contributions to the field of early detection and 
intervention in psychosis. State of the art clinical and biological psychiatry has focused 
on formulating prodromal stages for the examination of transition to psychosis (McGorry, 
Hartmann, Spooner, & Nelson, 2018; Schultze-Lutter et al., 2015). This has led to a 
notable rise of structural and functional imaging studies with individuals meeting clinical 
(CHR) and ultra-high risk (UHR) for psychosis criteria (Borgwardt, McGuire, & Fusar-
Poli, 2011; Fusar-Poli, Radua, McGuire, & Borgwardt, 2012). Structural brain changes 
associated with psychosis risk typically include grey matter volume (GMV) reductions in 
temporolimbic and prefrontal regions (Fusar-Poli et al., 2012). More specifically, 
volumetric decrease of the hippocampus is consistently found in schizophrenia patients 
(Adriano, Caltagirone, & Spalletta, 2012; van Erp et al., 2016) and demonstrated in 
schizophrenia genotypes (Harrisberger et al., 2016). The search for psychosis 
biomarkers is becoming increasingly important in the advent of machine-learning 
methods in psychiatry (de Wit et al., 2017; Fusar-Poli et al., 2019; Koutsouleris et al., 
2012). 
Using analysis of cortical volumes based on voxel-based morphometry (VBM) 
(Ashburner & Friston, 2000), transient changes may be captured, making VBM sensitive 
enough to detect brain structural deviations in clinical and nonclinincal phenotypes using 
cross-sectional and longitudinal designs. In healthy individuals, VBM correlates of 
schizotypal traits were reported in prefrontal regions (Nenadić, Lorenz, et al., 2015) and 
regions relevant to the frontostriatal system (Ettinger et al., 2012; Meller, Ettinger, Grant, 
& Nenadić, 2019; Pfarr & Nenadić, 2020). Additionally, regional volume enlargements of 
the precuneus in the parietal lobe were replicated in several previous investigations in 
nonclinical psychosis phenotypes (Meller, Schmitt, et al., 2020; Modinos, Egerton, 
McLaughlin, et al., 2018; Modinos et al., 2010). Twin studies uncover a liability for 
significant progressive volume changes among unaffected co-twins of schizophrenia 
patients (Brans et al., 2008). Brain volume also showed susceptibility towards 
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environmental risk factors for psychopathology, such as lower socioeconomic status and 
traumatic stress events (Gur et al., 2019). Volume reductions differ across prodromal 
and first episode stages (Bartholomeusz et al., 2017), and transition status in high-risk 
individuals (Smieskova et al., 2010). Neurodevelopmental aberrances may explain these 
converging findings from neuroimaging studies. Two time periods with a pivotal impact 
on psychotic trajectories through prefrontal neurodevelopment have been proposed: the 
early and gestational prenatal stages followed by adolescence (Selemon & Zecevic, 
2015). Pantelis et al. (2005) suggested that psychotic vulnerability may render the brain 
particularly vulnerable to anomalous postpubertal neurodevelopment, indicated by 
accelerated prefrontal GMV loss. Transition to psychotic illness may entail 
neurodegenerative processes involving medial temporal and orbital prefrontal regions 
(Pantelis et al., 2005). Critical developmental periods may also exist for stress 
responsiveness (Grace & Gomes, 2019).   
A limitation to VBM is the unknown extent of to which results are confounded by 
antipsychotics (Fusar-Poli et al., 2011) or illness factors (Owens et al., 2012) typically 
found in patients. Cortical surface parameters are therefore useful complementary 
approaches for neurobiological characterisation. This includes morphometry of cortical 
thickness and gyrification i.e., the folding pattern of gyri and sulci across the cortex 
(Zilles, Palomero-Gallagher, & Amunts, 2013). Cortical thickness differences in 
psychosis are linked to environmental risk factors such as urban upbringing (Besteher, 
Gaser, Spalthoff, & Nenadić, 2017) and developmental trauma and cannabis exposure 
(Habets, Marcelis, Gronenschild, Drukker, & van Os, 2011). Effects of environmental and 
genetic influences on cortical thickness also emerge for healthy psychosis phenotypes 
(Córdova-Palomera et al., 2014). These relationships seem to indicate aetiological 
gene×environment interactions that may be uncovered using different morphometric 
parameters. The largest share of cortical folding occurs during early human 
neurodevelopment. Starting around the 16th ontogenetic week, folding then surges 
dramatically in the period between the late second trimester and postnatal week 78, 
when the maximal gyrification index exceeds adult levels (Armstrong, Schleicher, 
Omran, Curtis, & Zilles, 1995). Surface-based morphometry (SBM) of cortical gyrification 
(Luders et al., 2006; Schaer et al., 2012) can give insight to anomalies during the early 
phase of brain morphological organisation and relationships with psychopathology 
(Nenadić, Maitra, Dietzek, et al., 2015; Spalthoff, Gaser, & Nenadić, 2018). A study of 
lifetime gyrification trajectories showed that overall cortical gyrification indices in normal 
development and aging were low in adulthood, accompanied by a low decrease rate 
(Cao et al., 2017). That study also showed deviation in gyrification trajectories in different 
diagnostic groups compared to healthy controls in adulthood, indicative of altered brain 
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aging in psychopathology.   
In summary, cross-sectional, longitudinal, genetic, and neuroimaging studies reflect a 
research stream that aims to characterise psychosis phenotypes on a wider spectrum 
outside of clinical nosology. By aiming to derive biomarkers in combination with extensive 
psychiatric genotypes these efforts facilitate the achievement of overarching mental 
health goals in the era of precision psychiatry (Fernandes et al., 2017; Gifford et al., 
2017). A prerequisite to these developments includes expanding the amount of 
investigations in subclinical psychosis phenotypes, thereby filling in the gaps along the 
psychosis continuum. Thus, the overall purpose of this dissertation is to combine 
different brain morphological and phenotypic parameters to address the lack of imaging 
studies in this field.   
 
1.3. Research aims and hypotheses  
 
Collectively the presented studies focus on the healthy section of the psychosis 
continuum. Using neurobiological, psychological and endophenotypic parameters, three 
studies presented in this dissertation aim to investigate psychosis phenotype diversity. 
Neurobiological correlates are examined using a set of different models.  
For this purpose of these objectives, the following hypotheses were examined:  
 
Hypothesis 1: Dimensional psychosis phenotypes are differentially associated with 
cortical gyrification in prefrontal, parietal, and precuneus regions. Associations between 
psychosis phenotype dimensions and regional cortical gyrification are mediated by 
cognition, which acts as an intermediate phenotype of psychosis liability.  
 
Hypothesis 2: Elevated subclinical psychosis phenotypes are negatively correlated 
with regional brain volumes, especially in regions implicated in schizophrenia. These 
associations are modulated by the severity of distress related to positive psychotic-like 
experiences. 
 
Hypothesis 3: The effect of subclinical psychosis phenotypes on medial temporal lobe 
(MTL) structures, an area implicated in the pathophysiology in schizophrenia, differs 
between dimensions of stable psychosis phenotypes (traits), psychotic-like 
experiences, and their interaction.   
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2. SUMMARY OF STUDY RESULTS 
2.1. STUDY 1. Cortical gyrification, psychotic-like experiences, and cognitive 
performance in nonclinical subjects.  
Evermann, U. Gaser, C., Besteher, B., Langbein, K., & Nenadić, I. (2020). Cortical gyrification, 
psychotic-like experiences, and cognitive performance in nonclinical subjects. Schizophrenia 
Bulletin, 46(6), 1524–1534. DOI: https://doi.org/10.1093/schbul/sbaa068 
Clinical phenomenology shows limited success in the identification of psychosis 
biomarkers (Hager & Keshavan, 2015). Endophenotypes, or intermediate phenotypes, 
provide a powerful alternative tools for biological psychiatry (Gottesman & Gould, 2003;  
Insel & Cuthbert, 2009). These neurophysiological and neurocognitive parameters  
(Myles, Rossell, Phillipou, Thomas, & Gurvich, 2017; Siever & Davis, 2004; Thaker, 
2008) tap into psychosis genotypes, eliminating the limitations associated with the 
boundaries of clinical syndromes. Cognitive deficits constitute one of the core symptom 
categories of schizophrenic disorders (Kahn & Keefe, 2013). Cognitive (dys)function in 
patients is related to illness duration and negative symptoms (Ito et al., 2015). 
Comparisons have shown that several domains including executive function, working 
memory (WM), and verbal fluency are consistently affected across the psychosis 
phenotype spectrum (Hou et al., 2016; Ivleva et al., 2012; Siddi, Petretto, & Preti, 2017), 
including individuals with a familial liability for schizophrenia (Gur et al., 2007). 
Furthermore, a neurodevelopmental model of schizophrenia is supported by findings 
suggesting that cognitive impairment also predates the clinical presentation of psychosis 
(Bora & Murray, 2014; Sheffield, Karcher, & Barch, 2018). Hence it may be expected 
that cognitive deficits indicative of prefrontal changes (Baker et al., 2019) are also linked 
to cortical gyrification (Docherty et al., 2015). Prefrontal gyrification deficits were present 
in bipolar and schizophrenia patients, which were also associated with measures of WM 
and intellectual function in the former group (McIntosh et al., 2009). A positive 
association between general cognitive ability and gyrification in prefrontal and parietal 
regions was shown in healthy subjects (Gregory et al., 2016). Another study using the 
gyrification index method (Schaer et al., 2012) has found a positive association between 
cortical gyrification and both cortical volume and WM performance (Gautam, Anstey, 
Wen, Sachdev, & Cherbuin, 2015).   
A part of the research questions addressed in Study 1 was especially influenced by 
findings from previous genetic studies (Toulopoulou et al., 2015, 2019) which modelled 
the causal role of cognition on the pathway to schizophrenia liability. Their results from 
both twin study (Toulopoulou et al., 2015) and polygenic risk score (PRS) (Toulopoulou 
et al., 2019) approaches suggested that the effect of genetics on schizophrenia risk 
passes partially through cognition. Instead of PRS or other genetic risk estimates, cortical 
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gyrification was implemented as a promising potential endophenotype (White & 
Gottesman, 2012). Firstly, it indexes early neurodevelopment and aberrances thereof, 
for example, prematurity impacting adult intelligence quotient (IQ) (Hedderich et al., 
2019), and secondly, it is associated with psychosis genotypes (Liu et al., 2016). The 
general objective of Study 1 was to examine associations between different dimensions 
of psychotic-like experiences (PLE) assessed by the Community Assessment of Psychic 
Experiences (CAPE, Stefanis et al., 2002) and cortical gyrification, and whether some 
variance in PLE dimension explained by regional cortical gyrification passes through 
estimated cognitive performance. For this purpose, we analysed cortical gyrification 
using whole-brain vertex-wise mean curvature-based method (Luders et al., 2006).  
The findings of Study 1 partially confirmed the predictions. In summary, the pattern 
underlying the results suggested overall negative phenotype-gyrification relationships, 
regional differences between PLE dimensions, and specificity for CAPE scales 
measuring PLE distress rather than PLE frequency (for which there were no 
relationships). In mediation models predicting PLE by regional gyrification, the pathway 
through cognition was nonsignificant. The statistically significant clusters were located in 
the left precuneus and right supramarginal to superior temporal gyrus (and a trend 
towards significance in the left inferior gyrus). A study in schizophrenia patients showed 
peak hypogyrification differences in the right precuneus and left supramarginal gyrus 
(Nesvåg et al., 2014). Hypergyrification of the right temporal lobe in patients with first-
episode schizophrenia (Harris et al., 2004), and the prefrontal and left parietal cortices 
in schizotypal disorder (Sasabayashi et al., 2020) have also been reported. Hence, the 
parietal and temporal clusters partially converge with neuroanatomical regions showing 
abnormalities in the schizophrenia spectrum (Matsuda & Ohi, 2018). Assuming 
increasingly distressed states accompany vulnerability (Hanssen, Bak, et al., 2005), 
isolated effects of the distress scale in these areas suggest varying degrees of 
vulnerability among psychosis prone phenotypes.  
A cluster within the right supramarginal, postcentral, insular, transverse temporal, and 
superior temporal regions was associated with depressive PLE. In light of previous 
findings supporting alterations in superior temporal gyrus (STG) gyrification using 
comparable morphometric methods (Besteher, Gaser, Langbein, et al., 2017; Schmitgen 
et al., 2019) there may be transdiagnostic indications attached to this finding. Temporal 
lobe pathology in psychosis is implicated in the course of illness (Takahashi et al., 2009) 
and may also result from genetic influences on neurodevelopment in psychopathology 
(Schork et al., 2019). This supports the impetus of studying neurodevelopmental markers 
across heterogeneous symptom domains, as findings from cortical gyrification in major 
depressive disorder (MDD) and psychosis are partially convergent regarding 
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neuroanatomical location. Study 1 provides partially consistent evidence in nonclinical 
subjects.  
A lack of (false discovery rate corrected) significant correlations between CAPE 
dimensions and neuropsychological measures suggests that cognitive deficits were too 
small to exert an effect on this pathway. Some common aetiological factor(s) might 
underlie all three parameters, and/or their influence on each other. The collective 
magnitude of effects, including cognitive deterioration, may reach a threshold in the 
clinical spectrum. A possibility proposed by Toulopoulou et al. (2019) states that genetic 
risk may first put cognition at increased risk for deficiency through several ways involved 
in neurodevelopment and may again contribute to symptom deterioration at a later point 
in time.  
In summary, Study 1 showed that positive and depressive subclinical PLE are negatively 
associated with gyrification of precuneus and supramarginal/temporal regions, 
respectively. Predicting positive or depressive PLE from regional gyrification was not 
significantly mediated through cognition. We propose that cognitive deficits may explain 
brain-behavioural relationship in increasingly vulnerable individuals with PLE and cortical 
aberrances of temporal regions are not psychotic per se but could signify general 
psychosis proneness or psychopathological vulnerability in the psychosis continuum. 
 
2.2. STUDY 2. Distress severity in perceptual anomalies moderates the relationship 
between prefrontal brain structure and psychosis proneness in nonclinical individuals.   
Evermann, U., Schmitt, S., Meller, T., Pfarr, J.-K., Grezellschak, S., & Nenadić, I. Distress severity 
in perceptual anomalies moderates the relationship between prefrontal brain structure and 
psychosis proneness in nonclinical individuals. (Manuscript submitted).  
 
In clinical practice, two-stage assessments (screening followed by standardised 
interviews) enhance discrimination between transient PLE and at-risk psychosis 
phenotypes (Addington, Stowkowy, & Weiser, 2015; Kline & Schiffman, 2014; Savill, 
D’Ambrosio, Cannon, & Loewy, 2018). In specialised care settings, some information 
may be especially useful to clinicians in this process, including affective symptoms 
(Falkenberg et al., 2015) and distress associated with PLE (Hanssen, Bak, et al., 2005). 
As previously seen in Study 1, distress is significantly associated with cortical surface 
morphology. In Study 2, we attempted to combine information from a low-level screening 
instrument (16-item Prodromal Questionnaire, PQ-16) (Ising et al., 2012) with brain 
structure to investigate this incongruence further. In addition to the overall PLE-level, we 
also aimed to investigate whether distress level associated with specific types of PLE 
would influence such relationships. With this objective, distress serving as an indicator 
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of PLE appraisal was considered a moderator to brain-phenotype relationships.  
In Study 2, it was shown that PLE level, but not PLE distress severity, was associated 
with regional brain structure. PLE total scores from the PQ-16 were associated with 
larger GMV in prefrontal, occipital fusiform, and lingual regions, while distress severity 
was not a significant estimator for GMV. Based on the positive PLE-brain structure 
relationship revealed through regression analysis, regional volumes extracted from the 
right superior and middle frontal gyri were targeted. These regions of interest (ROIs) 
were consistent with previous findings, which suggest that the dorsolateral prefrontal 
cortex (DLPFC) is repeatedly taxed in psychosis (Nenadić, Maitra, Langbein, et al., 2015; 
Wojtalik, Smith, Keshavan, & Eack, 2017). The PQ-16 assesses positive PLE but also 
contains two negative items (Ising et al., 2012). To specify distinctive dimensional 
regressors, the positive items were categorised into ‘delusional’ and ‘perceptual 
abnormalities’ components, which yielded two novel continuous subscales to be used 
for ROI volume estimation. Testing these two moderators showed that the 
PLE×perceptual abnormalities distress scale interaction was statistically significant in the 
regional brain volume of the right superior frontal gyrus, and marginally significant in the 
right middle frontal gyrus model (p=0.06). Distress severity for items conveying unusual 
thought content/delusional ideas did not moderate PLE associations with either ROI.   
Contrary to predictions, the positive relationship adds to previous studies in nonclinical 
cohorts that evidence larger volumes at higher PLE expressions (Nenadić, Lorenz, et al., 
2015), rather than volume reductions (Ettinger et al., 2012; Pfarr & Nenadić, 2020; 
Satterthwaite et al., 2016; Wang et al., 2015). One possible explanation for these 
inconsistencies in nonclinical phenotypes may relate to transitory PLE and stable (trait) 
phenotype estimator effects, or more specifically, the multidimensional structure of 
psychometric schizotypy and PLE. The positive dimension of the Multidimensional 
Schizotypy Scale (Kwapil, Gross, Silvia, Raulin, & Barrantes-Vidal, 2018) showed 
negative associations in the same regions of the dorsolateral prefrontal cortex (DLPFC) 
(Pfarr & Nenadić, 2020) as the PQ-16 of Study 2. However, only schizotypy was also 
associated with volume reductions in the anterior cingulate gyrus. On the other hand, 
PLE were uniquely correlated with volume of occipitotemporal gyrus, unparalleled in 
multidimensional schizotypy.   
As in Study 1, Study 2 utilised an instrument that gauges distress severity in addition to 
overall PLE load. Building on the findings from Study 1 and volumetric studies (Modinos 
et al., 2010; Nenadić, Lorenz, et al., 2015; Suzuki et al., 2005), Study 2 investigated 
whether distress severity modulates brain structural associations with PLE. Thus, Study 
2 contributes to the literature by elucidating prefrontal volume variation as a function of 
other additional attributes associated with psychopathology.   
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In short, the aim of Study 2 was an investigation of brain structural change in response 
to low-level PLE, which may be associated with elevated psychosis risk (CHR states) 
once a clinically meaningful threshold is surpassed. Defining a continuous subclinical 
phenotype across a preselection criterion threshold showed differential structural 
associations for the subclinical symptom level (overall screening score) not replicated for 
the distress level. Increased distress severity associated with perceptual PLE reduced 
the strength of the positive relationship between GMV and PLE in one of the DLPFC 
regions. These findings provide neurobiological evidence in keeping with cognitive 
interpretative models of psychosis (Brett, Heriot-Maitland, McGuire, & Peters, 2014; 
Brett, Johns, Peters, & McGuire, 2009; Underwood, Kumari, & Peters, 2016), suggesting 
that subjective interpretations of PLE mark shifts in vulnerability profiles. Furthermore, 
prefrontal correlates may be associated with compensatory mechanisms protecting 
individuals with psychosis proneness.  
 
2.3. STUDY 3. Nonclinical psychotic-like experiences and schizotypy: interactions 
and differential associations with hippocampal subfield and amygdala volumes.  
Evermann, U., Gaser, C., Meller, T., Pfarr, J.-K., Grezellschak, S., & Nenadić, I. Nonclinical 
psychotic-like experiences and schizotypy: interactions and differential associations with 
hippocampal subfield and amygdala volumes. (Manuscript submitted).  
 
Phenotype heterogeneity (Cowan & Mittal, 2020; Fusar-Poli et al., 2016; Seiler, Nguyen, 
Yung, & O’Donoghue, 2020) complicates research within the psychosis continuum. 
Several classifiers may aid in understanding potentially clinical trajectories in nonclinical 
phenotypes. Endurance of PLE underlies clinical outcomes (Dominguez, Wichers, Lieb, 
Wittchen, & van Os, 2011; van Os et al., 2009), and this persistence itself is influenced 
by further factors including stress reactivity (Collip et al., 2013) and insomnia (Reeve, 
Nickless, Sheaves, & Freeman, 2018). However, monitoring occasional PLE for their 
persistence would require thorough longitudinal assessments. On the other hand, the 
schizotypy framework provides stable personality traits beyond but also closely related 
to the emergence of PLE (Fonseca-Pedrero & Debbané, 2017; Kwapil et al., 2020). More 
lodged within the medical tradition of thought (Claridge, 2015), the first conceptualisation 
of the schizophrenic phenotype i.e., schizotypy by Rado (1953), describes 
schizophrenia-like characteristics below the threshold that would distinguish clinical 
diagnoses.  According to the fully dimensional model of schizotypy stemming from the 
individual differences and personality perspective (Claridge, 2015), schizotypy is a 
normal and adaptive personality variation that results in dysfunction at the extreme end 
representing illness.   
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Study 3 adopted the fully dimensional view of schizotypy and definitions by other authors 
who propose that schizotypy constitutes stable traits, while PLE are unstable states 
adhering to a symptoms-based approach (Debbané & Barrantes-Vidal, 2015; Fonseca-
Pedrero & Debbané, 2017). Furthermore, it has been suggested that PLE “…like overt 
psychotic symptoms, can be thought of as manifestations of positive schizotypy” 
(Barrantes-Vidal et al., 2015, p. S409). The contribution of state and trait phenotypes to 
subclinical psychosis symptoms also differs across the lifespan (Rössler, Hengartner, 
Ajdacic-Gross, Haker, & Angst, 2013), suggesting that their peak influences do not 
necessarily overlap. However, PLE are especially connected to the positive dimension 
of schizotypy and reflect temporal states in response to exogenous or endogenous 
events (Barrantes-Vidal et al., 2015).   
The aim of Study 3 was to combine trait phenotypes and PLE as estimators for brain 
structural variation. Since the schizotypy and PLE levels within nonclinical cohorts are 
expectedly small, a reliable structural outcome measure would be required to increase 
sensitivity to estimator effects. In schizophrenia, volume abnormalities are replicated in 
the hippocampus (van Erp et al., 2016), and such reductions already ensue during the 
prodromal stages of psychosis (McHugo et al., 2018; Walter et al., 2012). In a previous 
study, we showed that an interaction between schizotypy (negative×disorganised) 
dimensions explains left anterior and whole hippocampal volume variability, implying that 
volume is significantly reduced in individuals with high trait expressions on both 
schizotypy dimensions (Sahakyan et al., 2020). This finding in the so-called extended 
psychosis phenotype (van Os & Linscott, 2012), together with evidence from high-risk 
and clinical individuals (McHugo et al., 2018), supports an anterior to posterior gradient 
of hippocampal volume reduction in psychosis. Thus the anterior to posterior spread of 
hippocampal deterioration originating in the CA1 subregion is thought to indicate a 
pathophysiological process (Schobel et al., 2013).   
Building on this and a prior study investigating schizotypy only (Sahakyan et al., 2020),  
MTL structures were chosen. More specifically, this included volumetric estimations of 
amygdala and hippocampus subfield volumes. Along its longitudinal axis, the 
hippocampus may be partitioned into the dentate gyrus (DG), cornu ammonis (CA) 
subdivisons (1-4), subiculum, as well as the stratum radiatum, lacunosum and 
moleculare (Winterburn et al., 2013). Clinical studies mostly show negative associations 
between positive (Kühn et al., 2012; Mathew et al., 2014) and negative symptom 
dimensions (Haukvik et al., 2015; Kawano et al., 2015) and volumes of hippocampal 
subfields. In Study 3, outcomes were predicted based on these dimensional findings and 
translated to the four trait dimensions found in schizotypy (Mason & Claridge, 2006; 
Mason, Claridge, & Jackson, 1995).   
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The outcomes of Study 3 partially supported the predictions. Trait facets, rather than 
presumably transient signs of psychosis proneness, significantly explained hippocampal 
volume variance. It was shown that once all four schizotypy dimensions are entered 
together with the PLE scale as estimators for five left (uncorrected) and right (corrected 
for multiple comparisons) hippocampal subfield and amygdala volumes, left subicular 
and amygdala reductions were significantly explained by trait dimensions only. The 
approach utilised in Study 3 revealed that trait (positive and impulsive) psychosis 
phenotypes differentially relate to left subiculum – and partially amygdala - volumes 
following the longitudinal axis.   
3. DISCUSSION 
The overarching aim of these studies was to contribute neurobiological markers of 
nonclinical psychosis phenotypes. Building on evidence from the continuum hypothesis 
(Verdoux & van Os, 2002) at the phenotype level, and clinical neuroimaging studies, it 
was expected that symptom dimensions would result in correlates indicative of a 
neurobiological continuum. Study 1 examined the relationship between cognitive 
endophenotypes and a cortical marker of neurodevelopment in dimensional psychosis 
phenotypes. The findings showed that subclinical phenotypes are associated with 
regional gyrification reductions. However, prediction of PLE distress by regional 
gyrification was not mediated through IQ or global cognitive performance, therefore 
results only partially confirmed hypothesis 1. Study 2 revealed an association between 
larger regional volumes and PLE, which was contrary to predictions. The modulating 
effect of positive PLE distress levels on this relationship in two DLPFC regions was 
present for perceptual but not delusional components in one of these regions. Hence, 
hypothesis 2 was partially confirmed. Study 3 showed that variation in MTL structures is 
explained by some specific dimensions of schizotypy rather than PLE, confirming 
hypothesis 3 to some extent. The overall conclusion is that different subclinical psychosis 
phenotypes of variable endurance and quality are associated with regional cortical and 
variation. Furthermore, there was some evidence for modulatory relationships between 
state and trait psychosis phenotypes. In the following section, these findings will be 
integrated with each other and the wider literature starting with a brain systems 
perspective. Finally, an outlook on potential clinical applications and psychosis 
continuum models will be provided.  
3.1. Brain networks across the psychosis continuum 
3.1.1. Frontoparietal network regions  
SBM and VBM correlates of subclinical psychosis phenotypes were found in frontal, 
temporal, parietal, and medial temporal regions. In non-psychiatric individuals reporting 
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positive PLE, we found cortical gyrification (family-wise error-corrected p=0.08) and 
structural prefrontal correlates. Brain structural deficits in these regions are supported by 
findings in functional connectivity. Altered frontoparietal connectivity in psychosis 
(Lewandowski et al., 2019; Peeters et al., 2015) and ARMS (Schmidt et al., 2014) is 
thought to underlie typical cognitive deficits. A study differentiating psychosis patients by 
cognitive impairment showed intrinsic frontoparietal connectivity decreases in both 
groups compared to controls, and augmented reductions associated with cognitive 
impairment in the patient comparison (Lewandowski et al., 2019). Additionally, 
frontoparietal network alterations were shown in nonclinical subjects with PLE but without 
accompanying cognitive deficits (Fukuda et al., 2019). This implies that network 
disruptions may be a vulnerability antecedent in psychosis phenotypes before cognitive 
deficits are detectible. The associations between PLE and inferior prefrontal and 
precuneus gyrification (Study 1), and DLPFC volume (Study 2) are consistent with 
frontoparietal network nodes. Another clinical study found differences in frontoparietal 
and executive control resting-state networks, which entailed reduced connectivity in the 
left precuneus and increased connectivity in right middle and superior frontal gyri (Wolf 
et al., 2011). Precuneus correlates also underpin traits in agreement with Claridge’s 
model accounting for the adaptive characteristics in schizotypy (Nelson et al., 2013), 
including for instance, creativity (Burch, Pavelis, Hemsley, & Corr, 2006; Fink et al., 2014; 
Takeuchi et al., 2011).   
 
3.1.2. Default mode network and salience network regions 
An overlap between structural with functional networks, specifically the so-called triple 
network model (Menon, 2011), encourages multi-modal neuroimaging approaches to 
understand psychopathology. Structural (white matter) connections correspond to the 
functional connectivity occurring in resting-state networks (van den Heuvel, Mandl, Kahn, 
& Hulshoff Pol, 2009). In schizophrenia, cortical gyrification connectomes showed 
regional aberrances in anterior insula and DLPFC (Palaniyappan, Park, Balain, Dangi, & 
Liddle, 2015), and regional folding reductions in left precuneus and right temporal regions 
(Study 1) support overlaps with default mode (DMN) and salience network (SN) regions. 
The DMN encompasses the medial prefrontal cortex, posterior cingulate/precuneus, and 
temporal cortices, and characterises the intrinsic activity of the brain at rest (Raichle, 
2015). Connections between anterior cingulate cortex and the insular cortex, with linkage 
to the limbic regions, encompass the salience network (Menon & Uddin, 2010). The SN 
is primarily involved with internal and external stimulus integration while also receiving 
prefrontal inputs that guide behavioural responses (Palaniyappan & Liddle, 2012). Thus, 
Study 1 implicates the role of the precuneus as part of the DMN (Utevsky, Smith, & 
15 
 
Huettel, 2014) in individuals with positive PLE. Study 1 also demonstrated reduced 
gyrification of a cluster consisting of right supramarginal to superior temporal and insular 
regions associated with depressive PLE. This finding is supported by abnormalities in 
STG structure (Besteher, Gaser, Langbein, et al., 2017) and gyrification (Schmitgen et 
al., 2019) in the affective spectrum, and volumetric and functional STG abnormalities in 
psychosis (Crossley et al., 2009; Pettersson-Yeo et al., 2015; Takahashi et al., 2009). 
STG dysfunction in early psychosis is paralleled by GMV alterations (Pettersson-Yeo et 
al., 2015) and the association with cortical gyrification in nonclinical subjects partially 
supports neuroanatomical consistencies between imaging modalities. Crossley et al. 
(2009) demonstrated STG deactivation failure during WM tasks, suggesting disrupted 
frontotemporal connectivity in early (and to an intermediary degree in prodromal) 
psychosis.  
Changes to the SN and DMN systems in psychosis and MDD (Shao et al., 2018) are 
compatible with the notion that psychopathology operates at the level of larger brain 
circuitry systems (Menon, 2011). DMN hyperconnectivity and hyperactivity occur in both 
psychotic and affective psychopathology (Whitfield-Gabrieli & Ford, 2012). Mallikarjun et 
al. (2018) showed activation of superior temporal and DMN regions during auditory 
hallucinations, and increased functional connectivity between salience and DMN nodes 
in first-episode psychosis. SN nodes modulate switching between DMN (deactivation) 
and central executive network (CEN) (activation) (Sridharan, Levitin, & Menon, 2008). In 
schizophrenia, SN is dysregulated ( White, Gilleen, & Shergill, 2013), and reduction of 
SN control on DMN/CEN functional connectivity is also related to hallucinatory severity 
(Manoliu et al., 2014). Insular dysfunction, which is thought to underlie SN alterations is 
compatible with the dopamine hypothesis of psychosis (Palaniyappan & Liddle, 2012). 
SN alterations are present at a transdiagnostic level (Peters, Dunlop, & Downar, 2016), 
where they are responsible for aberrant salience and emotional appraisal in 
schizophrenia (Lee et al., 2014) and MDD (Jankowski et al., 2018).  
In agreement with this, temporal lobe GMV (Kandilarova, Stoyanov, Sirakov, Maes, & 
Specht, 2019) and functional alterations (Fitzgerald, Laird, Maller, & Daskalakis, 2008) 
are found in MDD. STG volume decrease is already present in nonclinical individuals 
with familial schizophrenia liability (Rajarethinam, Sahni, Rosenberg, & Keshavan, 
2004). Thus, one interpretation may constitute that temporal and insular regions are 
neurodevelopmental points of convergence, or fluidity, between depression and 
psychosis prone phenotypes. Clinical comorbidity between psychosis and depression 
further supports this (Hartley, Barrowclough, & Haddock, 2013), paralleled by a frequent 
accompaniment of depressive symptoms in psychosis prodromal stages (Fusar-Poli, 
Nelson, Valmaggia, Yung, & McGuire, 2014). Study 1 suggested that temporal lobe 
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folding correlates overlapping in clinical psychopathologies are partially found in the 
subclinical dimensions. Together with previous studies (Alloza et al., 2020; Orr, Turner, 
& Mittal, 2014; Schmidt et al., 2015), this lends strength to the argument that brain 
network alterations in major psychiatric disorders may also be extendible to nonclinical 
spectra such as the psychosis continuum.   
Accumulating evidence for neuroanatomical correlates dependent on general risk factors 
(Hibar et al., 2015; Popovic et al., 2020) may explain why mental health outcomes are 
heterogeneous and insufficiently characterised by diagnoses alone. Developing either 
psychotic or depressive syndromes is steered by multiple factors that could be both 
additive and interactive. From an aetiological perspective symptom dimensional overlaps 
might be explained by some common genetic (Lee et al., 2019; Liu et al., 2020) and/or 
neurodevelopmental pathways with divergent pathogenesis (Lefebvre et al., 2016) and 
symptomatic unfolding over time. For example, shared vulnerability such as childhood 
trauma possibly contributes equally to development and persistence of psychotic and 
depressive symptoms (van Dam et al., 2015). This is supported by polygenic risk for 
bipolar disorder, and schizophrenia also associating with depression (Musliner et al., 
2019). Expanding this idea, neuroanatomical convergence also supports fluidity between 
psychoses, from schizophrenia to bipolar disorders and psychotic mood disorders. 
Findings from within the clinical psychosis continuum show presence of frontoparietal 
network disruptions in schizophrenia and affective psychosis (Baker et al., 2014), and 
SN abnormalities in schizophrenia, MDD, and bipolar disorder (Yang et al., 2019). 
Finally, this would even lend support to continuity within psychoses. After all, overlapping 
clinical presentations had already brought the late Kraepelin to reconsider his strict 
dichotomisation of manic-depressive insanity and dementia praecox (Angst & Gamma, 
2008). Besides spectra of psychotic and affective disorders, further studies aggregating 
general psychopathology (Caspi et al., 2014) are required to investigate the extent of 
parietal and temporal lobe alterations in a broad range of psychiatric diagnoses (Baker 
et al., 2019; Picó-Pérez, Radua, Steward, Menchón, & Soriano-Mas, 2017; Wise et al., 
2017). It must also be noted that frontotemporal or salience and default mode network 
systems require appropriate analyses of functional activity and network connectivity 
(e.g., Barber, Lindquist, DeRosse, & Karlsgodt, 2018).   
 
3.2. Medial temporal lobe structures and striatal dopamine regulation 
The major dopaminergic pathways implicated in the pathogenesis of psychosis include 
the mesocortical (Dandash, Pantelis, & Fornito, 2017) and mesolimbic (Stahl, 2018) 
pathways. Howes and Kapur (2009) described presynaptic striatal dopamine 
dysregulation as the final common pathway to psychosis in schizophrenia, and 
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importantly, psychosis proneness in general. This is further supported by antisaccade 
movement changes in schizotypy that indicate striatal dopaminergic alterations in 
endophenotypes (Ettinger et al., 2005; Thomas et al., 2020). The positive schizotypy 
dimensions may be an intersection between dopaminergic regulation (Grant et al., 2013; 
Mohr & Ettinger, 2014) and a general proneness of the striatal and MTL systems also 
related to the emergence of PLE. Howes et al. (2020) showed that striatal dopamine 
synthesis capacity increased positive symptoms in CHR individuals and proposed that 
dopamine fluctuations occurring in at-risk states could drive short-term PLE, but their 
course (persistence and severity) possibly depends on further dopamine dysregulation. 
Next to the mainstay mesolimbic dopamine hypothesis (Stahl, 2018), the glutamate 
hypothesis has important implications for the prefrontal and MTL structures. A 
relationship between hippocampal glutamate and striatal dopamine is shown in ARMS 
(Stone et al., 2010) and first-episode psychosis (Jauhar et al., 2018). Hippocampus 
structure integrity is sensitive to the general effects of trauma (Logue et al., 2018), and 
MTL neurotransmitter circuitry is implicated in psychotic deterioration (Fusar-Poli et al., 
2020; Lieberman et al., 2018). N-methyl-D-aspartate receptor (NMDAR) hypofunction 
gives rise to γ-aminobutyric acid (GABA)-ergic interneuron disinhibition, which increases 
the glutamatergic tone of pyramidal cells leading to allostatic adaption and hippocampal 
volume reductions over time (Davies et al., 2019; Lisman et al., 2008). The resulting 
increase in hippocampus pyramidal excitatory activity in turn enhances striatal 
hyperdopaminergia leading to an attenuated psychotic state (Lisman et al., 2008). This 
pathophysiological model implicates hippocampal structures as markers of disease 
progress and encourages new treatment approaches in the CHR states (Davies et al., 
2019).  
Subclinical psychosis phenotypes also present with changes in corticostriatal 
connectivity (Dandash et al., 2015; Waltmann et al., 2018) and hippocampal activity 
(Modinos, Egerton, Mcmullen, et al., 2018; Wolthusen et al., 2018). Modinos et al. (2018) 
reported increased resting perfusion of the right hippocampus in high schizotypy, but not 
the midbrain and striatum, suggesting that heightened hippocampal activity is 
represented on the continuum, but resilience may play a role in nonclinical individuals. 
Stress is an important contributor to hippocampal overactivity leading to increased 
midbrain dopaminergic responsivity and striatal dopamine (Grace & Gomes, 2019; 
Lodge & Grace, 2011; Mizrahi et al., 2012). This also fits in with the model of Howes and 
Kapur (2009), suggesting that positive psychotic symptoms develop against a backdrop 
of ‘multiple hits’ (effects of e.g. drugs, stress, genes), which underlines the role of general 
liability and acute alterations in psychosis proneness. Study 3 provided a detailed 
investigation of the hippocampal structures in association with trait psychosis 
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phenotypes and PLE. The findings suggested that hippocampal subiculum variation is 
distributed on the psychosis continuum, as this occurred as a function of the 
schizotypy×PLE interaction. In study 2, the interaction of PLE and perceptual PLE 
distress severity was associated with structural differences in the prefrontal regions, 
which implicates frontostriatal circuitry (Dandash et al., 2017). The effects of distress 
severity perhaps indicate a proxy for additional psychopathological processes.   
Siever and Davis (2004) outline some compensatory factors that could mitigate the 
impact of psychosis proneness. For example, temporal deficits are countered by 
increased prefrontal functional capacity, or reduced subcortical dopaminergic 
responsiveness buffers against frontal hypodopaminergia. This may also explain the 
absence of an inverse relationship between general cognitive performance or IQ and 
psychosis proneness reported in Study 1. A neurodevelopmental vulnerability may be 
mitigated through spared cognition, which would support the buffering model (Siever & 
Davis, 2004). Additionally, the results of Study 2 are also in line with a previous study in 
healthy psychosis prone individuals, showing that general intelligence may confer 
prefrontal compensation in the frontostriatal system (Meller, Ettinger, et al., 2020).   
 
3.3. Using neurobiological markers to unravel phenotypic continuity 
At the centre of this dissertation is the question of whether neurobiological markers can 
depict dimensional subclinical psychosis phenotypes, thereby possibly adding towards 
a better understanding of the latter. Quantitative changes can explain PLE variation in 
the population ranging from nonclinical signs to a need for care (Johns & van Os, 2001). 
Several factors pave the way from unspecific PLE to a need for care in prodromal and 
clinical syndromes, however this relationship may also be discontinuous (Johns & van 
Os, 2001). Kaymaz and van Os (2010) commented that the continuum model may be, 
at least partially, confounded by underlying categorical structures consisting of different 
groups that vary in e.g., cognitive impairments. In a subsequent meta-analysis they then 
showed that clinical course is modified by severity and persistence of PLE (Kaymaz et 
al., 2012). In some PLE linked to a need for care (e.g., nonverbal hallucinations) this 
association is mediated by distress (Bak et al., 2005). Another study showed quasi-
continuous relationships between symptom dimensions, genetic and environmental risk 
factors, and the severity of psychotic symptoms (Binbay et al., 2012). Binbay et al. (2012) 
suggested that proxy variables for genetic risk impacted psychosis severity in a non-
linear positive way. Environmental factors, such as urbanicity and childhood adversity, 
showed linear effects, while the non-linear effect of cannabis increased risk in the clinical 
spectrum.  
This idea of a seemingly non-linear trajectory or continuum may also translate to the 
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neural level. Modifiers were supported by Study 2, where distress severity showed a 
modulatory effect in the right superior frontal gyrus, and Study 3 demonstrated a state-
trait interaction effect on subiculum volume. In the clinical spectrum, neurobiological 
alterations may not map linearly onto early psychosis staging models (Bartholomeusz et 
al., 2017). Brain structural findings suggest that temporal lobe pathology in psychosis 
evolves over time, but early neurodevelopmental vulnerability, such as indicated by 
cortical gyrification alterations, may already be present beforehand (Pantelis et al., 2005; 
Selemon & Zecevic, 2015). Other aetiologically relevant factors, such as increased 
environmental risk (e.g. traumatic life events) may increase psychosis proneness 
through cognitive and emotional pathways (Gibson, Alloy, & Ellman, 2016). Intact 
cognitive capacities and emotional well-being may protect nonclinical individuals with 
persistent PLE, despite trauma history comparable to clinical psychosis in some cases 
(Peters et al., 2016). Incorporating individualised environmental risk scores (Vassos et 
al., 2020) may further elucidate multifactorial models. For example, obstetric 
complications linked to reduced prefrontal gyrification in both schizophrenia and healthy 
controls indicates shared early influences (Haukvik et al., 2012) but through 
gene×environment interactions (van Os, Rutten, & Poulton, 2008) or the additive effects 
of both factors (Mittal, Ellman, & Cannon, 2008), negative neurodevelopmental offsets 
(Gregory et al., 2016; Hedderich et al., 2019) may increase likelihood of later psychotic 
illness through cognitive deficits (Toulopoulou et al., 2015). Just as psychotic disorders 
have substantial polygenic variation (International Schizophrenia Consortium, 2009), 
environmental factors alone are not sufficient to account for psychotic illness (Gibson et 
al., 2016; Stilo & Murray, 2019). Based on the reviewed studies in frontoparietal, 
temporal, and hippocampal regions, there is evidence to assume at least partial 
continuity at a neurobiological level, but protective factors may explain a share of 
variability. 
 
3.4. Implications for clinical applications and future research 
The works of this dissertation suggest that SBM and VBM findings can reflect psychosis 
proneness. The results support a consistent representation of frontoparietal alterations 
across the psychosis continuum (Schmidt et al., 2015), which could also serve a clinical 
utility. For example, frontoparietal activity during cognitive control predicted symptom 
improvement among patients with recent psychosis onset, which could help to stratify 
early intervention (Smucny, Lesh, & Carter, 2019). Further studies in the subclinical 
spectrum could combine persistence (Fonville et al., 2019), distress, and neuroimaging 
makers to investigate their utility in predicting a need for care.   
In Study 2, it was shown that structural DLPFC correlates were modulated by distress 
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levels for perceptual anomalies but not delusional characteristics. The relationship 
between positive PLE dimensions may explain this. Hanssen et al. (2005) suggested 
that increased distress levels associated with perceptual PLE form the antecedent for 
delusion formation. Follow-up assessments in a large cohort showed that psychosis 
onset forecasted by hallucinatory experiences was significantly augmented when 
delusion formation took place over the course of observations (Krabbendam et al., 2004). 
Compared to the occurrence level, impairing, i.e., distressing PLE, are more densely 
connected to one another, and paranoia is an important contributor to these relationships 
(Murphy, McBride, Fried, & Shevlin, 2018).   
Thus, there may be several routes through which distress and harm emerges in PLE. A 
need for care is accompanied by an increased engagement of specifically psychotic 
appraisals (Lovatt, Mason, Brett, & Peters, 2010). Cognitive appraisals of PLE such as 
‘caused by others’ significantly predict distress increase, while ‘spiritual’ appraisals 
predict lower distress (Brett et al., 2014). Perhaps severe cognitive deficits would also 
associate with maladaptive cognitive appraisals of psychotic symptoms in an additive 
manner. Brett et al. (2009) reported a relationship between cognitive/attentional deficits 
and maladaptive metacognitive beliefs about PLE. Furthermore, if depression and 
psychosis prone individuals share abnormal brain circuitry that relates to the emotional 
appraisal of internal and external events (Peters et al., 2016), both phenotypes could 
respond to low-level emotion regulation interventions (Liu, Chan, Chong, Subramaniam, 
& Mahendran, 2020; Osborne, Willroth, DeVylder, Mittal, & Hilimire, 2017; Picó-Pérez et 
al., 2017).  
Together, these investigations showed that PLE and schizotypy provide elegant 
analogues to clinical studies as they reduce confounds and inadequate assignments to 
control groups for failure to recognise liability (Barrantes-Vidal et al., 2015; Grant, 2015). 
Given the low validity of PLE for the prediction of prodromal syndromes (Schultze-Lutter 
et al., 2014), neuroanatomical correlates of protective features and resilience are worth 
exploring in future studies. These may concentrate on potentially modulating factors that 
may influence the course of clinical significance attached to dimensional trait- or state-
based subclinical psychotic experiences.   
 
3.5. Limitations and conclusions  
A general shortcoming is the use of cross-sectional study designs. The presented studies 
build on the assumption of a continuum where, for example, PLE transience or longevity 
would influence long-term clinical outcomes (Dominguez et al., 2011). However, 
temporal changes can only be addressed using longitudinal designs. With the exception 
of schizotypy (Study 3), the presented models therefore capture neuroanatomical 
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correlates of PLE, which possibly represent states of unknown duration. Differences 
between psychometric assessments of PLE could further lead to some inconsistencies. 
There is an abundance of psychometric assessments of subclinical psychotic 
experiences without a unifying terminology for these phenomena (Seiler et al., 2020). 
Since Study 3 was an enlarged sample of Study 2, a common limitation was a skewed 
age distribution, which may affect the generalisability of VBM findings (Bora & Baysan 
Arabaci, 2009). In Study 1, cognition was a nonsignificant mediator of the relationship 
between regional gyrification and PLE, which may have been explained by 
neurocognitive invariance between high and low PLE scorers. However, without a 
subgroup comparison of neurocognitive outcomes, this remains speculative. In 
schizophrenia, the largest effects for cognitive deficits are observed for verbal memory 
and WM (Fatouros-Bergman, Cervenka, Flyckt, Edman, & Farde, 2014). Using a global 
measure of cognitive performance, rather than specific tasks known to produce large 
effects in case-control comparisons, may also contribute to a potential disguise of 
mediation effects.   
Determining the degree of psychotic specificity attributed to dimensional correlates also 
extending into general psychopathology is methodologically challenging. Modinos et al. 
(2014) demonstrated neuroanatomical subtypes for GMV reductions in UHR with 
comorbid depression and anxiety disorders relative to UHR without comorbidity. 
Subclinical neuroimaging studies may need to consider heterogeneity, e.g., 
developmental stage or genetic risk (Barkhuizen, Pain, Dudbridge, & Ronald, 2020; 
Fonville et al., 2019). The inclusion of genotype data, such as PRS, would have arguably 
strengthened the scope of all three studies. Furthermore, while it could be possible that 
gyrification correlates for the depressive CAPE dimension in Study 1 were mediated by 
a general latent vulnerability, the positive CAPE dimension was not associated with 
gyrification of the temporal and supramarginal regions. Mixed regional hypo- and 
hypergyrification correlates in MDD and schizophrenia implying some neuroanatomical 
commonalities in clinical spectra require more elucidation in the subclinical phenotypes. 
Given the unknown extent of (physiological) commonalities and potentially specific 
neurodevelopmental trajectories, such tentative speculations require further 
investigations. 
To conclude, three cross-sectional studies provide evidence that subclinical psychotic 
traits and states possess cortical neuroanatomical correlates. A continuum -although 
probably not linear in nature- implicates the frontal, parietal, and temporal lobe regions 
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5. SUMMARY  
Psychosis unifies a collective of disorders characterised by symptom dimensions 
(Gaebel & Zielasek, 2015). Purposefully delimited clinical descriptors of schizophrenia 
spectrum and psychotic disorders (American Psychiatric Association, 2013) impose 
challenges on the identification of aetiological and clinically meaningful predictors. The 
disassembly of psychiatric diagnoses into their elementary symptom dimensions has 
helped formulate psychosis phenotypes fitted on a psychosis continuum (Verdoux & van 
Os, 2002). Aetiological models of psychosis may be studied through schizotypy and 
transient psychotic experiences (Barrantes-Vidal et al., 2015; Nelson, Fusar-Poli, & 
Yung, 2012), collectively termed subclinical psychosis phenotypes. The dimensional 
psychometric structures of these phenotypes varying in temporal stability (Linscott & van 
Os, 2013; Mason et al., 1995; Stefanis et al., 2002), and their implications might be 
further consolidated when paired with neuroimaging parameters (Siever & Davis, 2004).  
Three neuroimaging studies aimed to examine the relationship between subclinical 
psychotic phenotypes and neurobiology. Surface and volume-based morphometric 
(VBM) methods were implemented to examine the variety of cortical and subcortical 
signatures of different phenotype dimensions. Study 1 investigated whether cortical 
surface gyrification -a maker of genetic and developmental influences on cortical 
morphology (Docherty et al., 2015; Haukvik et al., 2012)- is associated with dimensional 
psychosis prone phenomena (Konings, Bak, Hanssen, van Os, & Krabbendam, 2006; 
Stefanis et al., 2002). Early cortical organisation contributes to cognitive capacities in 
later life (Gautam et al., 2015; Gregory et al., 2016; Papini et al., 2020). Given that 
cognitive deficits are present in psychosis prone and clinical samples to varying extents 
(Hou et al., 2016; Siddi et al., 2017), Study 1 also explored the mediating role of cognition 
(both as a general measure and intelligence quotient) as a psychosis endophenotype in 
the relationship between regional gyrification and PLE distress. Study 2 and Study 3 
used VBM to investigate structural brain correlates for psychotic-like experiences (PLE) 
and trait psychosis phenotypes (schizotypy). Different PLE facets (quantity and distress 
severity) (Hanssen, Bak, et al., 2005; Ising et al., 2012) were used to estimate whole-
brain grey matter volume, followed by interaction models in subsequent prefrontal 
regions of interest (Study 2). The medial temporal lobe includes the hippocampal 
subfields, which are regions of interest in psychosis pathophysiology (Lieberman et al., 
2018; Mathew et al., 2014; Schobel et al., 2013). Based on a previous study in 
schizoytypy (Sahakyan et al., 2020), Study 3 examined the relationship between 
schizotypal trait dimensions (Mason et al., 1995) and PLE, and their interactions, and 
hippocampal subfields and the amygdala.  
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The results of Study 1 showed that psychometrically assessed PLE were associated with 
reduced gyrification in parietal and temporal regions, indicating that psychosis proneness 
correlates with neurodevelopmental factors (Fonville et al., 2019; Liu et al., 2016). A lack 
of mediating pathways between regional gyrification and PLE suggested that cognition 
effects may emerge in larger samples (Mollon et al., 2016) and/or increasingly psychosis 
pone phenotypes. Elaborating on the distinction between PLE quantity versus distress, 
Study 2 showed that PLE load, but not distress severity, were associated with volume 
increases in prefrontal and occipitotemporal regions. At increased distress severity for 
perceptual abnormalities, PLE were associated with regional volume reductions of the 
superior frontal gyrus.  Study 3 showed differential relationships between schizotypy 
dimensions and volumes of the MTL that are involved in the pathophysiology of 
schizophrenia. PLE per se did not associate with amygdala or hippocampal subfield 
volumes, but a positive association between the hippocampal subiculum and PLE was 
moderated by positive schizotypy. Study 3 underscored the enhanced usefulness of 
schizotypy as an endophenotype in psychosis research when its multidimensional 
organisation (Grant, 2015; Vollema & van den Bosch, 1995) is respected.  
The results support the use of psychosis symptom dimensions, showing different 
(positive and negative) neuroanatomical associations. While case-control studies in 
schizophrenia show consistent volume reductions of the prefrontal and temporal cortices 
(Haijma et al., 2013; Honea, Crow, Passingham, & Mackay, 2005), these findings 
contribute to more heterogeneous volumetric relationships in nonclinical individuals. 
Reduced regional cortical gyrification proposes a continuous distribution of 
neurodevelopmental impacts. Distress severity and schizotypy occasioned modulatory 
effects in prefrontal and hippocampal subfield volumes, respectively. Collectively, these 
three cross-sectional studies extend previous research suggesting that dimensional 
phenotypes show neuroanatomical variation supportive of a psychosis continuum 
possibly characterised by an underlying non-linearity (Bartholomeusz et al., 2017; 






Unter dem Sammelbegriff der Psychosen versteht sich eine Gruppe von Störungen mit 
vielfältigen Symptomen (Gaebel & Zielasek, 2015). Fall-Kontroll-Studien untersuchen 
anhand kategorialer Diagnosen (American Psychiatric Association, 2013) 
neurobiologische Veränderungen einhergehend mit psychotischen Erkrankungen. Im 
dimensionalen Krankheitsverständnis beruht die Bezeichnung klinischer Phänotypen auf 
der Annahme eines Kontinuums unterschiedlicher Symptome (Stefanis et al., 2002; 
Verdoux & van Os, 2002). Dieser dimensionale Ansatz kann das Auftreten psychotischer 
Merkmale bei Gesunden erklären und gleichzeitig zur erweiterten Erforschung 
ätiologischer Modelle genutzt werden (Barrantes-Vidal et al., 2015; Nelson et al., 2012). 
Zu den subklinischen Phänotypen gehören einerseits stabile Merkmale wie schizotype 
Traits (Mason et al., 1995), so wie vermeintlich transiente psychose-nahe Erlebnisse 
(Linscott & van Os, 2013; Stefanis et al., 2002). Mittels hirnmorphometrischer Methoden 
können neuroanatomische Parallelen und Abgrenzungen zu den klinischen 
Krankheitsbildern untersucht werden (Nenadić, Lorenz, et al., 2015; Siever & Davis, 
2004; Taylor et al., 2020). 
Drei Querschnittstudien untersuchten mögliche Zusammenhänge zwischen 
psychometrisch erfassten subklinischen Psychose-Phänotypen und der kortikalen 
Struktur. Studie 1 widmete sich der Analyse der kortikalen Oberflächengyrierung, welche 
einen Indikator für die frühe kortikale Entwicklung in Abhängigkeit von genetischen und 
Entwicklungsfaktoren (Docherty et al., 2015; Haukvik et al., 2012) darstellt. Diese wurde 
im Zusammenhang mit dimensionalen psychose-nahen Erlebnissen untersucht. Die 
kortikale Faltung erklärt auch spätere kognitive Leistungen (Gautam et al., 2015; 
Hedderich et al., 2019; Papini et al., 2020), welche bei PatientInnen, Hoch-Risiko 
Phänotypen und Gesunden mit einem familiären Psychoserisiko Verschlechterungen 
aufweisen (Hou et al., 2016; Siddi et al., 2017). Anhand von Mediationsmodellen wurde 
der Einfluss neurokognitiver Funktionen auf den Zusammenhang zwischen regionaler 
Gyrifizierung und psychose-nahen Erlebnissen untersucht. Studien 2 und 3 untersuchten 
hirnstrukturelle Korrelate anhand von Voxel-basierter Morphometrie. Studie 3 verfolgte 
das Ziel, sowohl die Ausprägung als auch die Facette des entstandenen 
Belastungsgrades durch subklinische Erlebnisse (Hanssen, Bak, et al., 2005; Ising et al., 
2012) auf der hirnstrukturellen Ebene abzubilden. Die Auswirkung des Zusammenspiels 
dieser beiden Facetten (Ausprägung und dimensionsspezifische Belastung) auf die 
Struktur präfrontaler Areale wurde mit Moderationsanalysen untersucht. Basierend auf 
bestehenden Ergebnissen zur Reduktion hippocampaler Volumina in den frühen und 
späten Stadien psychotischer Erkrankungen (Lieberman et al., 2018; Mathew et al., 
2014; Schobel et al., 2013), sowie bei der Schizotypie Gesunder (Sahakyan et al., 2020), 
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untersuchte Studie 3 die medial temporalen Strukturen. Es wurden die Zusammenhänge 
zwischen unterschiedlichen Schizotypie-Dimensionen und subklinischen psychose-
nahen Erlebnissen, sowie deren Interaktion, mit den Volumina einzelner hippocampaler 
Teilvolumina und der Amygdala untersucht.  
Die Ergebnisse zeigten unterschiedliche regionale oberflächenbasierte Korrelate der 
kortikalen Faltung in Abhängigkeit von der Merkmalsdimension. Reduktionen der 
kortikalen Gyrierung in parietalen und temporalen Bereichen stimmten mit den Regionen 
neuroanatomischer Veränderungen aus klinischen Studien bei Schizophrenie-
PatientInnen überein. Der Effekt der Gyrierung auf die Ausprägung subklinischer 
Phänotypen in diesen und präfrontalen Bereichen wurde jedoch nicht durch die kognitive 
Leistung vermittelt. Studie 2 zeigte, dass die Ausprägung des subklinischen Phänotyps, 
jedoch nicht die mit solchen Erlebnissen verbundene Belastung, mit einer Zunahme der 
grauen Substanz in präfrontalen und okzipitotemporalen Arealen assoziiert waren.  Eine 
Volumenreduktion im Gyrus frontalis superior wurde durch die Interaktion der 
subklinischen Phänotyp Ausprägung mit der Belastung durch perzeptuelle Merkmale 
bedingt. Hinsichtlich der Assoziationen in den medial temporalen Strukturen konnte 
gezeigt werden, dass strukturelle Variation der Amgygdala und einzelner hippocampaler 
Teilvolumina eher durch stabile schizotype Traits, als durch psychose-nahe Erlebnisse, 
erklärt wird. Im hippocampalen Subiculum moderierte positive Schizotypie jedoch den 
Zusammenhang zwischen transienten Erlebnissen und Volumenzunahme. Somit hebt 
Studie 3 die besondere Rolle stabiler Endophänotypen (Barrantes-Vidal et al., 2015) 
sowie die Berücksichtigung der Dimensionalität subklinischer Phänotypen (Grant, 2015; 
Vollema & van den Bosch, 1995) im Psychosespektrum hervor.  
Die Ergebnisse der drei Studien unterstützen den dimensionalen Ansatz, bei dem 
unterschiedliche psychotische Merkmale im Einzelnen untersucht werden. Diese 
psychose-nahen Erlebnisse wiesen bei Gesunden kortikale Assoziationen in psychose-
relevanten präfrontalen und temporalen Arealen auf (Haijma et al., 2013; Honea et al., 
2005), welche jedoch im Gegensatz zu klinischen Befunden heterogenere Beziehungen 
aufweisen. Im subklinischen Bereich ließen sich zudem Abweichungen der kortikalen 
Faltung feststellen (Fonville et al., 2019; Liu et al., 2016), welche einen kontinuierlichen 
Zusammenhang mit entwicklungsbedingten Faktoren erkennen lassen. Die 
modifizierenden Eigenschaften von schizotypen Traits und der Belastung durch 
perzeptuelle Auffälligkeiten auf jeweils positive und negative Zusammenhänge in 
hippocampalen und präfrontalen Strukturen deuten darauf hin, dass innerhalb des 
Psychose-Kontinuum möglichweise nichtlineare kortikale Veränderungen stattfinden 
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Background: Psychotic-like experiences (PLE) are present in 
nonclinical populations, yet their association with brain struc-
tural variation, especially markers of early neurodevelopment, 
is poorly understood. We tested the hypothesis that cortical 
surface gyrification, a putative marker of early brain develop-
ment, is associated with PLE in healthy subjects. Methods: We 
analyzed gyrification from 3 Tesla MRI scans (using CAT12 
software) and PLE (positive, negative, and depressive symptom 
dimensions derived from the Community Assessment of 
Psychic Experiences, CAPE) in 103 healthy participants (49 
females, mean age 29.13 ± 9.37 years). A subsample of 63 in-
dividuals completed tasks from the Wechsler Adult Intelligence 
Scale and Controlled Oral Word Association Test. Estimated 
IQ and a composite neuropsychological score were used to ex-
plore mediation pathways via cognition. Results: Positive PLE 
distress was negatively associated with gyrification of the left 
precuneus. PLE depression dimension showed a negative as-
sociation with gyrification in the right supramarginal and 
temporal region. There was no significant mediating effect of 
cognition on these associations. Conclusion: Our results sup-
port a neurobiological psychosis spectrum, for the first time 
linking an early developmental imaging marker (rather than 
volume) to dimensional subclinical psychotic symptoms. While 
schizophrenia risk, neurodevelopment, and cognitive function 
might share genetic risk factors, additional mediation ana-
lyses did not confirm a mediating effect of cognition on the 
gyrification-psychopathology correlation.
Key words:  cognitive function/endophenotype/
neurodevelopment/subclinical/magnetic resonance imaging 
(MRI)
Introduction
Schizophrenia is associated with core cognitive deficits 
predictive of risk for illness onset,1 treatment response, 
and recovery.2,3 Hallmark dysfunctions consistently in-
clude general intellectual ability4 and domains of atten-
tion, working memory, and verbal fluency.5 While gradual 
changes in cognitive, perceptual, and negative symptoms 
mark the prodromal phase in the ultra-high risk (UHR) 
state, performances in these domains are also reduced in 
non-afflicted first-degree relatives6,7 and healthy adults 
endorsing psychosis phenotypes including schizotypy 
and psychotic-like experiences (PLE).8,9 Previously, we 
reported positive correlations between psychosis prone-
ness in healthy adults and gray matter (GM) volumes in 
the precuneus, inferior, and parietal cortical areas.10 GM, 
white matter, and functional abnormalities in fronto-
parieto-temporal network areas,11,12 parahippocampal, 
and cingulate gyri are frequently reported in schiz-
ophrenia.13,14 Cortical and subcortical alterations in 
prefrontal network GM volume15,16 and functional con-
nectivity between frontal, temporal, hippocampal, and 
striatal regions across the psychosis continuum17–20 are 
evident, yet somewhat inconclusive regarding direction-
ality. Modinos et al21 detected GM volume increases in the 
precuneus and anterior cingulate cortex in high schizo-
typy as well as the medial posterior cingulate areas in high 
positive PLE. Another study did not support regional pre-
frontal GM reductions associated with schizophrenia in 
twins and relatives of patients, suggesting that deficits in 
prefrontal executive function, rather than GM variation, 
are attributable to genetic liability for schizophrenia.22
Altogether these findings demonstrate that disease-
stage and genetic risk profile account for overlap and dis-
crepancies in functional and cortical variation, especially 
in prefrontal and precuneus regions. Neurobiological 
correlates of polygenic risk for psychotic disorders and 
cognitive disturbance support accumulating evidence for 
2 neurodevelopmentally meaningful endophenotypes.23–26 
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The shared variance between polygenetic risk for schizo-
phrenia and cognition-related pathways in a causal me-
diation model suggests that cognitive disturbance lies 
upstream to schizophrenia liability and not vice versa.27 
This is further supported by putative pathways involving, 
eg, calcium signaling associated with executive function 
in schizophrenia.28
A growing body of research recognizes cortical 
gyrification as a neurobiological marker of early genetic 
and environmental modulation in cortical surface mor-
phology in schizophrenia. Signifying the degree of cor-
tical folding that peaks during early neurodevelopment, 
gyrification has been strongly implicated as an early 
endophenotype in psychopathology.29 Increased spa-
tial resolution is achieved by quantifying the local 
gyrification of individual surface vertices.30 A  recent 
study using vertex-wise local gyrification index (GI),31 
for instance, has shown an association with polygenic 
risk indicating an early neurodevelopmental disturbance 
in schizophrenia.32 Compared with cortical thickness, 
morphometry of cortical gyrification might be less sus-
ceptible to heterogeneous illness-related effects.33 This 
can aid to delineate etiological phenomena across groups 
of varying phenotype expression without confounds of 
acute neuroanatomical changes in schizophrenia34 and 
antipsychotic treatment thereof.35 Thus, gyrification pro-
vides a novel approach to map differential phenotype 
correlates,36,37 which are continuously expressed in the 
general population.38 Case-control studies of gyrification 
in schizophrenia have pointed to prefrontal and temporal 
alterations, but have not always been consistent.37,39–41 
While psychotic phenomena such as auditory hallucin-
ations have been linked to cortical folding abnormalities 
in schizophrenia patients,42 studies of cortical folding in 
nonclinical subjects are rare.43 Hence, there is a paucity in 
the studies linking gyrification to subclinical phenomena, 
such as PLE, that form part of the psychosis spectrum. 
These mostly transitory PLE38 feature positive (delu-
sional, hallucinatory, and dissociative experiences) and 
negative (affective flattening, avolition, and social with-
drawal) subclinical phenomena corresponding to the typ-
ical dimensions of schizophrenia spectrum disorders.44,45 
Recently, a study using local GI found a significant role of 
the persistence of psychotic experiences during a 2-year 
follow-up period on gyrification reduction in the left tem-
poral gyrus and brain volume in left occipital and right 
prefrontal brain regions,23 thus replicating morphological 
findings in regions implicated in schizophrenia. Negative 
associations of cortical volume and local GI in orbito-
frontal, parietal, and temporal regions were driven by the 
interaction of polygenic risk score and psychotic experi-
ences. However, these symptoms were not differentiated 
by dimensionality or quality, such as PLE frequency or 
symptom-related distress accounting for cortical varia-
tion in relevant areas, including left precuneus and right 
inferior temporal pole.46 
Despite some initial volume-based morphometric 
studies, it is unclear whether more specific morphometric 
markers related to core processes such as early develop-
ment/cortical gyrification are related to different dimen-
sions of PLE (positive, negative, and depressive) and 
cognitive function. Our aims were, therefore, 2-fold: our 
primary objective, based on previous GM volumetric 
studies of PLE, was to test the hypothesis that variation 
in cortical surface morphology is associated with different 
dimensions of subclinical PLE in healthy nonclinical in-
dividuals. Guided by previous voxel-based morphometry 
(VBM) findings,10 we expected associations between psy-
chosis proneness (assessed by CAPE) and gyrification 
in prefrontal, superior parietal, and precuneus regions. 
Secondly, we tested the hypothesis that PLE-associated 
gyrification is mediated by cognitive function in this non-
clinical cohort. This hypothesis was based on the findings 
in the clinical spectrum, showing close relations between 
cognition and clinical outcomes across high-risk, first-
episode, and multi-episode patients47,48 and cognition 
pathways mediating some genetic risk on schizophrenia 
in a recent study.27
Methods
Subjects
We included 103 healthy participants (49 males, 54 fe-
males; mean age = 29.13 years, SD = 9.37) recruited from 
the local community. We obtained written informed con-
sent from each participant for the study protocol approved 
by the local Ethics Committee of the Jena University 
Medical School and in line with the Declaration of 
Helsinki. The sample is based on a previously published 
community sample, which was enlarged subsequently.10 
Mean laterality index for the overall sample was 73.78 
(SD = 36.38) right-handedness.49 Subjects were recruited 
from the local community by advertising (press releases 
and word of mouth) and were compensated for study 
participation. They first underwent telephone screening 
and subsequent screening in person to assess the inclu-
sion and exclusion criteria. A semi-structured interview 
was used to screen subjects for the absence of current 
or previous psychiatric disorders, including substance 
abuse or dependence, psychiatric or psychological treat-
ment, intake of psychopharmacotherapy, or first-degree 
family liability for psychotic disorders. Subjects were 
also excluded if  any neurological disorders, untreated 
major chronic or acute organic medical conditions, his-
tory of traumatic brain injury/loss of consciousness, 
or intellectual disability/ learning impairment (IQ < 
80) were present. Next, all subjects underwent screening 
about lifetime history of psychiatric and general medical 
health care, and illicit substance and alcohol use. These 
screening questions were a requirement for subsequent 
scanning to ensure the inclusion of healthy volunteers 













Clinically meaningful levels of psychosis risk can be de-
tected in healthy individuals using self-report measures, 
such as the 42-item Community Assessment of Psychic 
Experiences (CAPE).50 The CAPE is widely used to as-
sess lifetime prevalence of PLE in the general population 
whilst available in multiple languages. These strengths 
were recently demonstrated in a meta-analysis45 and a 
cross-cultural study,51 and it may be cost-effectively em-
ployed in non-specialized settings to examine traits as-
sociated with psychosis proneness.52,53 Including positive 
(CAPE-pos, 20 items) and negative (CAPE-neg, 14 items) 
subscales, the CAPE provides a comprehensive and reli-
able45 self-report measure of the dichotomous symptom 
dimensions reflecting both frequency and distress related 
to psychosis-prone traits. Additionally, we also explored 
the depressive symptom (CAPE-dep) subdimension, 
which consists of an 8-item scale from the 3-factor 
model.44
Neuropsychological Assessment
In a subsample of 63 healthy subjects (28 females; 
mean age 30.32  years, SD  =  10.47), we assessed cogni-
tive performance using multiple subtests of the German 
Wechsler Intelligenztest für Erwachsene (WIE),54 the 
German adaptation of Wechsler Adult Intelligence Scale 
(WAIS-III)55 neuropsychological testing battery, and the 
Controlled Oral Word Association Test (COWAT).56 
A  general estimate of intelligence (IQ) was obtained 
from a German-language multiple-choice vocabulary 
test (Mehrfachwahl-Wortschatz-Intelligenztest, MWT-
B).57 The MWT-B provides a resourceful approximation 
of crystallized intelligence.58 The combination of cogni-
tive tasks typically utilized in clinical schizophrenia25,59 
and UHR samples60 from the 2 extensive test batteries 
included Letter-Number Sequencing task (LNS), Digit 
Symbol Coding task (DSCT) of the WAIS-III, Letters 
FAS, and Animals of the COWAT (table 1).
MRI Acquisition and Surface-Based Morphometric 
Analysis
We obtained high-resolution T1-weighted scans using 
a 3 Tesla Siemens Tim Trio scanner (Siemens) with 
standard quadrature head coil and MPRAGE sequence 
for all subjects. Images were visually inspected followed 
by automated data quality check with homogeneity bias 
correction and tissue segmentation of images, followed 
by surface-based morphometry (SBM) analysis con-
ducted using the CAT12 toolbox, v12.5 r1363 (Christian 
Gaser, Structural Brain Mapping Group, Jena University 
Hospital; http://www.neuro.uni-jena.de/cat12/) within 
SPM12 v7219 (Statistical Parametric Mapping, Wellcome 
Trust Centre for Neuroimaging; http://www.fil.ion.ucl.
ac.uk/spm/software/spm12/) for Matlab R2017a (The 
MathWorks, Inc.). This novel pipeline allows for the com-
putation of surface-based parameters based on, eg, the 
mean curvature. Images were smoothed using a Gaussian 
kernel with 20-mm full width at half  maximum, as recom-
mended for vertex-wise gyrification in the CAT12 user 
manual (http://www.neuro.uni-jena.de/cat12/CAT12-
Manual.pdf). All subjects passed both the visual quality 
inspection and the CAT12 data quality checks. Together, 
all scans from 103 participants reached a weighted av-
erage (IQR) of 86.01% (range 82.32%–86.55%) corre-
sponding to a quality grade B.
Statistical Analysis
For statistical analysis of CAPE-gyrification associations 
(N = 103), we applied general linear models (GLM) im-
plemented in SPM12 and the CAT12 toolbox using CAPE 
subscale scores as predictors for local gyrification, while 
covarying for age and sex nuisance in the vertex-wise anal-
ysis (i.e. multiple linear regression models). We applied 
familywise error (FWE) cluster-level correction at P < .05 
(with initial P < .001 uncorrected peak-level thresholding) 
for significance testing.61 Secondly, in the subsample of 
n  =  63 subjects, we examined the relationship between 
neuropsychological predictors and CAPE outcome vari-
ables. Due to previously reported negative relationships 
between cognitive measures and psychosis proneness,8 we 
carried out 1-tailed partial correlations using Statistical 
Package for the Social Sciences (SPSS, Version 25, IBM 
Corp.). Finally, in this subsample, we explored mediating 
effect IQ and cognition on mean extracted predicted 
values in anatomical regions-of-interest (ROI) from the 
primary GLM analysis (ie, CAPE-gyrification association) 
as predictors and CAPE as outcome variables using the 
ordinary least squares (OLS) regression analysis imple-
mented in PROCESS Version 3.362 for SPSS. Model coeffi-
cients P-values were adjusted with the false discovery rate 
(FDR)63 correction for multiple comparisons using R.64 
For mediation model predictors, we used mean gyrification 
estimates across Desikan-Killiany atlas regions.65
Results
PLE Measures
In our whole sample, subjects scored on CAPE-pos di-
mension with mean frequency 1.24 (SD =0.18, range 
1.00–2.15, kurtosis = 5.80, skewness = 1.87) and mean dis-
tress 1.64 (SD = 0.50, range 1.00–3.13, kurtosis = −0.10, 
skewness = 0.45), CAPE-neg dimension with mean fre-
quency 1.72 (SD = 0.43, range 1.07–3.14, kurtosis = 1.10, 
skewness  =  0.97) and distress mean 1.88 (SD  =  0.65, 
range 1.00–3.50, kurtosis = −0.61, skewness = 0.49), and 
CAPE-dep scale with mean frequency 1.69 (SD = 0.40, 
range 1.13–3.88, kurtosis  =  7.99, skewness  =  2.05) and 
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Cortical Gyrification and PLE
For the CAPE-pos scale, we found cluster-level signifi-
cant (P = .015, FWE-corr.) effects in a cluster comprised 
of 178 vertices in the precuneus/cuneus region of the left 
hemisphere. We also found a trend-level effect for this 
scale in a cluster comprising 112 vertices in the left pars 
triangularis extending from the inferior prefrontal lobe to 
the pars opercularis region in the left middle frontal region 
(P = .080, FWE-corr.) (figure 1). CAPE-neg was associated 
with gyrification in the right posterior and isthmus cingu-
late area; however, these correlations were not significant 
at the chosen P < .05 FWE-correction level. GLM with 
CAPE-dep yielded negative associations with gyrification 
spanning supramarginal to superior temporal gyrus (STG) 
regions (P  =  .001, FWE-corr.) (figure 2; supplemen-
tary table 2). All results significant at the P < .05 FWE-
threshold concerned CAPE PLE-associated distress levels.
Neuropsychological Findings
Nonparametric and where appropriate parametric corre-
lational analyses between individual raw scores of each 
neuropsychological subtest and CAPE frequency and 
distress scores were conducted to explore the relation-
ship between cognitive and PLE phenotype variables. 
Correlation coefficients from partial 1-tailed correlation 
analyses controlled for age and sex are shown in table 2.
Mediation of ROI-Associated PLE via IQ and 
Cognition
Using the extracted mean predicted gyrification values 
of the 3 ROI identified in the primary analysis of 
gyrification (left precuneus, right STG, and the FWE-
trend-level sig. left inferior prefrontal cluster), we con-
ducted mediation analyses to predict PLE distress levels. 
A  global neuropsychological performance measure was 
computed from z-transformed raw scores added together 
to obtain a single composite score per participant. In 
separate models, global cognitive measure and MWT-B 
IQ estimate were entered as mediators. Global cogni-
tive performance significantly predicted MWT-B esti-
mated IQ [F(1,61) = 31.16, P < .001, R2 = 0.34]. There 
was no significant mediating effect of either estimated IQ 
or global cognitive performance in the prediction of di-
mensional PLE distress in the subsample. This is seen in 
the inclusion of null values in 10 000 bootstrap-sampled 
confidence intervals of indirect effect coefficients in sup-
plementary table S1.
Discussion
This study tested 2 hypotheses in healthy individuals with 
varying levels of PLE. First, we tested the effect of PLE 
on gyrification. Subsequently, we tested the individual ex-
planatory contribution of cognitive performance in brain 
regions significantly associated with PLE. Both neural and 
cognitive variables were considered as endophenotypes 
with some shared genetic variance. In this study, we pro-
vide a first evidence of subtle neurodevelopmental var-
iations in cortical areas linked to subclinical psychotic 
symptoms in nonclinical healthy subjects.
Unlike previous studies on PLE, which used volume-
based imaging markers (VBM or cortical thickness), our 
gyrification approach relates PLE more specifically to 
the variation of a neurodevelopmental marker. Previous 
Table 1. Demographic and Cognitive Sample Characteristics of 103 Healthy Adults 
Variable N Mean SD Skewness Kurtosis
Age 103 29.13 9.37 1.80 2.68
Female (%) 49 (47.60%)     
IQ (MWT-B estimate) 103 105.28 12.08 1.30 1.20
Neuropsychological assessment
 Age 63 30.32 10.47 1.52 1.48
 Female (%) 28 (44.40%)     
 IQ (MWT-B estimate) 63 108.70 13.42 0.94 −0.10
 MWT-B Score 63 29.22 3.48 −0.03 −0.53
 WAIS-III
  Arithmetic 63 16.41 3.78 −0.48 −0.78
  Digit symbol coding task 63 83.63 14.93 −0.04 −0.48
  Matrix reasoning 63 20.89 3.45 −0.72 −0.21
  Digit span 63 19.03 3.69 0.05 −0.73
  Information 63 19.92 5.53 −0.77 −0.43
  Letter-number sequencing 63 13.17 2.55 −0.44 −0.51
 COWAT
  Letters FAS 63 39.84 12.08 0.27 −0.71
  Animals 63 25.83 6.32 0.20 −0.15
Note: Of 103 healthy adults, 63 participants also completed neuropsychological tasks from the Wechsler Adult Intelligence Scale (WAIS-












animal and human studies have shown cortical gyrification 
to result primarily from complex neurodevelopmental 
processes, beginning at week 16 of gestation and ex-
tending into early childhood.66 Between ages 2 and 6, the 
cortical folding organization reaches a peak29 terminating 
into a considerably stable marker after adolescence with 
little variation across the lifespan.67 A  recent study of 
gyrification in manifest schizophrenia compared with 
healthy controls found convergence between regions of 
structural GM alterations and cortical thickness; how-
ever, threshold-significant gyrification results were more 
distinctive.37 In line with these findings, we report PLE 
gyrification effects in the prefrontal and temporal regions. 
Past studies focused on gyrification patterns in clinical 
psychotic disorders39,68 but investigations within the sub-
clinical spectrum of psychotic symptoms found across 
general population cohorts are lacking. A few studies that 
focused on dimensional PLE were almost exclusively lim-
ited to VBM10 and cortical thickness,69 leading to a lack 
of findings to infer on neurodevelopmental alterations 
within the wider psychosis continuum. In the present 
sample, a subclinical positive psychosis phenotype cor-
related negatively with gyrification, a marker linked to 
perinatal and early neurodevelopment.
Higher PLE distress in the CAPE-pos dimension 
was associated with reduced gyrification in the inferior 
frontal gyrus of  the prefrontal lobe at the subthreshold 
FWE-corrected significance level. Similar to psychotic 
samples, positive subclinical psychotic signs are associ-
ated with prefrontal cortical organization, underlining 
their relevance in a dimensional psychosis spectrum. 
Discriminating gyrification correlates between bipolar 
disorder I and schizophrenia showed some specificity of 
alterations in anterior medial prefrontal and orbitofrontal 
Table 2. One-Tailed Partial (Covariates Age and Sex) Spearman’s (rs) and Pearson’s (r; in Italics) Correlation Coefficients for 
Neuropsychological Subtest Raw Scores and IQ Estimated by MWT-B and Global Neuropsychological Composite Scores Correlated 
With Dimensional Community Assessment of Psychic Experiences (CAPE) Scales With Uncorrected (P) and False Discovery Rate 
Adjusted (Padj) Significance Levels
Positive Dimension Negative Dimension Depressive Dimension
Frequency Distress Frequency Distress Frequency Distress
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cortices for schizophrenia compared with controls. 
While hypergyrification in regions of  affective processing 
was unique in bipolar disorder, regions associated with 
cognition were pronounced in both diagnostic pheno-
types with some anatomical divergence.40 This raises the 
question of  whether prefrontal correlates of  positive 
psychotic symptoms are a widespread trend at both non-
clinical and transdiagnostic levels. Regulatory changes 
of  the dopaminergic and glutamatergic systems linked 
to typical neurocognitive symptoms of  schizophrenia70,71 
and specifically prefrontal variation72–74 perhaps also 
translate to prefrontal morphological and functional 
signatures in individuals with increased positive PLE. 
In contrast to positive prefrontal effects (gyrification 
increase) reported in schizophrenia,37 gyrification pat-
terns in the left inferior frontal gyrus showed a trend for 
a negative association in our finding. This discrepancy 
may be reflective of  the fluctuations in endophenotype 
effects across the psychosis spectrum spanning from 
minor subclinical symptoms in the general population, 
over increased symptom frequency in high-risk subjects, 
to those individuals developing schizophrenia spectrum 
disorders. In order to further support this interpretation, 
larger nonclinical and clinical samples would have to be 
combined to test linear vs. nonlinear relationships across 
such a spectrum.
Prefrontal structural variation within the psychosis 
spectrum,75 extending to psychosis proneness signified by 
PLE, is robust and associated with neurodevelopmental 
processes,76 such as synaptic pruning aberrances.77 A pre-
vious study reported impairments on selective domains 
such as verbal knowledge and working memory but 
not processing speed to be associated with PLE.7 While 
none of our results survived FDR-corrections, the trends 
might suggest heterogeneity dependent on scales, dimen-
sions, and cognitive domain. Both estimated IQ and the 
global cognition scale comprising all individual tasks 
showed low to medium (uncorrected) negative correl-
ations with the frequency of positive PLE. Together with 
previous findings of cognition mediating the genetic risk 
of schizophrenia, ie, cognitive dysfunction preceding 
schizophrenia-liability,27,78 this may suggest that in-
creased cognitive performance achieves neuroprotective 
effects in the presence of PLE. This notion is supported 
by the positive effects of increased cognitive reserve in 
first-episode psychosis patients on global function and 
Fig. 1. Logarithmic P-value maps of significant negative correlations of cortical gyrification and CAPE-pos scale in 103 healthy 
individuals (P < 0.001, uncorrected, for display purposes) (top). Cohen’s d maps of effect sizes for uncorrected correlations of 












negative symptoms in a 2-year follow up.79 The positive 
association of general intelligence80 and working memory 
with regional cortical gyrification81 further corroborates 
the functional findings of a parieto-frontal-integration 
model underlying intelligence variation.82 Altered pre-
frontal development might impact on the functional 
integrity of such networks, thus leading to changes in 
cognitive function. This neural-behavioral framework es-
tablished in nonclinical populations may be extended for 
cognitive reserve and compensatory capabilities in at-risk 
mental health states. Volumetric integrity of these net-
work nodes, ie, frontal, temporal, and parietal regions, is 
also featured in UHR subjects resilient against the transi-
tion to psychosis over a 6-year period.83
We found evidence for the negative effects of depres-
sive symptoms on gyrification in the right STG and 
supramarginal regions. Left-sided STG also showed GM 
increase associated with low-level depressive symptoms 
in another healthy sample.84 Convergence of decreased 
functional activity between psychotic disorders and 
major depressive disorder (MDD) highlights the critical 
role of the STG within the salience network in major 
psychiatric diagnoses. Another study also investigated 
cortical folding in MDD patients based on the whole-
cortex mean curvature presented here.85 Within the pa-
tient group, clinical outcomes such as symptom severity 
were negatively associated with gyrification in parietal, 
occipitotemporal, and prefrontal cortices. However, the 
group comparison showed that MDD is associated with 
right STG hypergyrification pointing toward heightened 
vulnerability. Here, the endorsement of subclinical de-
pressive states was associated with reduced gyrification of 
the right STG, which together with hypergyrification in 
diagnosed MDD proposes plastic alterations associated 
with the dopaminergic salience system and its role in cog-
nitive interpretative processes ensuing over the course of 
illness.86,87 These and our observations in the depressive 
spectrum, as well as STG-associations in schizotypy and 
schizophrenia,88 may also indicate the absence of psycho-
pathological and/or trait specificity, which in turn may be 
a result of symptom overlap.
There was a notable specificity for the PLE distress 
scale among the present results. The utility of CAPE as 
a screening tool for prodromal phenomena in clinical 
and non-specialized early treatment settings is partic-
ularly owed to its distinction of frequency and distress 
Fig. 2. Logarithmic P-value maps of significant negative correlations of cortical gyrification and CAPE-dep scale in 103 healthy 
individuals (P < 0.001, uncorrected, for display purposes) (top). Cohen’s d maps of effect sizes for uncorrected correlations of 
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experienced due to PLE.89,90 High positive PLE levels, if  
perceived distressful, may, therefore, tap into higher psy-
chopathological risk burden, supported by the covariance 
of positive and depressive symptoms.91 Another study 
differentiating risk variants demonstrated that the rela-
tionship between PLE and subjective distress experienced 
due to PLE is moderated by the levels of trait schizotypy.92 
Dimensionality and psychosis specificity of the chosen 
scales may explain discrepancies in the directionality of 
precuneus GM volume in schizotypy,10,93 which is further 
factored into positive and negative psychosis-prone traits 
with differential cognitive outcomes.94 Moving along 
the spectrum, negative clinical outcomes such as immi-
nent transition to psychosis are accompanied by inten-
sified tissue loss and cortical thinning,95–97 notably in the 
precuneus, parietal, and temporal regions.98 In agreement 
with notions of dynamic neurobiology,99 our findings 
map long-term cortical effects associated with subjective 
negatively perceived PLE, which are not attributed to dis-
ease progression but instead to vulnerability. Contrary to 
significant GM volume findings,10 the absence of cortical 
gyrification alterations for the CAPE-neg dimension sug-
gests that the surrogate neurodevelopmental surface pa-
rameter is not sensitive to the effects of clinical avolition, 
affective flattening, and social anhedonia reflecting 
transdiagnostic features of psychosis spectrum disorders.
While we did not find a mediating effect of either esti-
mated IQ or global neuropsychological performance, they 
showed low to medium (uncorrected) correlations with 
the frequency of positive PLE. We confined our analysis 
to ROI correlated with PLE distress levels but propose 
that PLE frequency may be of greater importance in 
these models. This conservative approach, together with 
variation in sample sizes, may cause underestimation of 
true mediator effects, constituting one of the main limita-
tions of the present study. Siddi et al8 showed that differ-
ences in neuropsychological performance between high 
and low schizotypy individuals were predominantly small 
(attention, visuospatial working memory, learning, short-
term visual, and long-term memory) to medium (verbal 
working memory) sized. A post hoc sensitivity analysis 
with an 85% power criterion showed that the size of the 
subsample included in the present mediation analysis was 
only sufficient to detect medium effects (ƒ2  =  0.18) of 
additional cognitive predictors. This might also explain 
our lack of significant findings (after multiple compar-
ison correction) for CAPE-cognition associations. Future 
efforts should, therefore, achieve wider PLE variance 
and compare metrics of local GI with mean curvature. 
Additionally, weaknesses regarding the present IQ esti-
mate needs to be pointed out. IQ estimation based on the 
MWT-B and educational level are not independent,58 and 
global estimates from comprehensive neuropsycholog-
ical batteries could increase robustness. Also, other cog-
nitive tests such as those tapping into visuospatial and 
motor skills, which were not included in our test battery 
despite showing heritability in schizophrenia,100 might 
be useful for future studies. The cross-sectional design 
allows for inferences about the natural state of cortical 
gyrification at an average age of about 30 years when the 
influence of time-invariant subclinical psychotic traits 
reaches a peak,101 but not across the lifespan.67 Using the 
gyrification metric as a proxy measure of early genetic in-
fluence on cytoarchitecture, its stability may be tested in 
PLE combined with cumulative risk burden and clinical 
trait-state markers. Longitudinal designs with increased 
PLE variability are required to address such time variants 
and effects of PLE heterogeneity. Despite limited under-
standing of cytoarchitectural mechanisms involved in 
gyrification in the psychosis spectrum, this study together 
with previous neuroimaging research suggests that differ-
ences in PLE dimensionality correspond to distinctive ge-
netically determined neurobiological characteristics.
Besides previously mentioned limitations, our explicit 
investigation of the subclinical spectrum warrants some 
considerations. To our knowledge, few studies including 
different patient groups across the psychosis spectrum, eg, 
schizotypal personality disorder,41 exist, which calls for fur-
ther research in the subclinical range. Here, we operation-
alized CAPE symptom dimensions derived by a 3-factor 
solution. However, further partitioning of subscales re-
sulting in more PLE phenotypes in exchange for lower in-
dices of construct validity102 offers an alternative research 
avenue to these dimensions. Future studies might also 
consider white matter changes related to PLE, which have 
been linked to symptom dimensions in schizophrenia.103,104
In conclusion, we report evidence for a relationship 
between variation in cortical gyrification and subclin-
ical psychosis phenotypes in the nonclinical spectrum. If  
cognition influences psychotic pathogenesis, interactions 
between cognitive and neurobiological endophenotype 
levels may be associated with attenuated PLE on the clin-
ical spectrum end.
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In the general population, psychosis risk phenotypes occur independently of attenuated 
prodromal syndromes. Neurobiological correlates of vulnerability could help to 
understand their meaningfulness. Interactions between the occurrence of psychotic-like 
experiences (PLE) and other psychological factors e.g., distress related to PLE, may 
distinguish psychosis prone individuals from those without risk of future psychotic 
disorder. We aimed to investigate whether a) correlates of total PLE and distress b) 
symptom dimension-specific moderation effects exist at the brain structural level in non-
help-seeking adults reporting PLE below and above the screening criterion for clinical 
high-risk (CHR). Methods: We obtained T1-weighted whole-brain MRI scans from 104 
healthy adults from the community without psychosis CHR states for voxel-based 
morphometry (VBM). Brain structural associations with PLE and PLE distress were 
analysed with multiple linear regression models. Moderation of PLE by distress severity 
of two types of positive symptoms from the Prodromal Questionnaire (PQ-16) screening 
inventory was explored in regions-of-interest after VBM. Results: Total PQ-16 score was 
positively associated with grey matter volume (GMV) in prefrontal regions, occipital 
fusiform and lingual gyri (p<0.05, FDR peak-level corrected). Overall distress severity 
and GMV were not associated. Examination of distress severity on the positive symptom 
dimensions as moderators showed reduced strength of the association between PLE 
and rSFG volume with increased distress severity for perceptual PLE. Conclusions: In 
this study, brain structural variation was related to PLE level, but not distress severity, 
suggesting specificity.  In healthy individuals, positive relationships between PLE and 
prefrontal volumes may indicate protective features, which supports the insufficiency of 
PLE for the prediction of CHR. Additional indicators of vulnerability, such as distress 
associated with perceptual PLE, weaken the positive brain structure relationship. Brain 
structural findings may strengthen clinical objectives through disentanglement of 
innocuous and risk-related PLE. 
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1. Introduction  
Prevention of psychosis spectrum disorders relies on early risk detection [1]. Prediction 
of transition to psychosis is particularly enhanced when clinically validated assessments 
are employed in targeted samples found in specialised mental health services [2]. On 
the other hand, the use of instruments to assess clinical high risk (CHR) states in general 
non-help-seeking populations produces weak predictive estimates of the true risk for 
imminent psychosis [3]. This shortcoming has been encountered by psychometric 
developments building on two-staged assessments of psychosis CHR states by 
screening and semi-structured clinical interviews, which enables improved clinical 
efficiency and accuracy [4]. Originally validated in a general mental health help-seeking 
population, the abbreviated 16-item version of the Prodromal Questionnaire [5] (PQ-16) 
sufficiently screens for psychosis ultra-high risk (UHR) states [6]. Together the Prodromal 
Questionnaires (92, 21, and 16-item versions)[5–7] are among the most widely used 
CHR screening tools [8]. Previous studies have employed the PQ-16 among help-
seeking adults [9] and adolescents [10], as well as nonclinical populations [11, 12] [for a 
review see ref 13]. 
The prevalence of subclinical psychotic experiences exceeds that of psychosis in the 
general population [14], but self-reported psychotic-like experiences (PLE) themselves 
constitute an inadequate criterion for attenuated psychotic syndromes [15]. Besides 
clinical prodromal symptoms, screening inventories such as PQ-16, therefore, capture 
PLE in a broader perspective. Among CHR individuals, motivation to seek help for 
distressful prodromal symptoms is increased by the burden of affective symptoms 
leading to greater functional decline [16]; these factors are also captured by semi-
structured interviews for attenuated psychotic syndromes [17].  In the general population, 
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evidence exists that persistence of PLE [18], distress [19, 20], and emotional context 
[21], depression, and reduced functioning [22] associated with positive PLE indicate 
elevated clinical relevance. The importance of distress for the differentiation between 
PLE with reduced clinical significance as, for instance, in developmental cohorts [23] and 
attenuated psychosis risk was also reflected in the uptake of an additional distress 
severity subscale to the prodromal screening inventory [7].  
Multiple neuroimaging studies compared brain morphology in ultra-high risk (UHR) for 
psychosis to healthy controls or first-episode psychosis patients [24–27]. In contrast to 
case-control brain imaging studies, which have focused on UHR and first-episode 
psychosis [28], the nonclinical spectrum (i.e., the occurrence of sparse PLE in healthy 
subjects) has received less attention despite recent findings of dimensional relations on 
the phenotype level [29, 30]. A continuous relationship between infrequent psychotic-like 
or subclinical symptoms towards a clinical spectrum [31–33] permits a hypothesised 
relation to neural markers that have been associated with CHR or disease status. This 
may add to the current understanding of the brain-behaviour relationships in the 
psychosis spectrum and the development of biomarkers in the early intervention field. 
Previous studies report associations between subclinical psychotic experiences and 
brain volume, as well as functional and cortical surface variation [34, 35],  some of which 
converge with alterations typically found in the manifest psychosis spectrum and 
affective disorders[36]. Across the literature, PLE are associated with structural change 
in diverse cortical regions, e.g., orbitofrontal and medial temporal lobes [37] and the 
parietal regions [38]. However, a strong effect for PLE associated with any particular 
cortical regions derived by meta-analysis is presently lacking. A recent study from our 
group showed consistent relationships with volume reductions in prefrontal and anterior 
cingulate regions across multidimensional schizotypy [39], representing a trait-level 
schizophrenia endophenotype [40, 41]. Furthermore, the relationship between positive 
schizotypy and PLE [42–44] is considered to reflect biological psychosis prone 
components within schizophrenia endophenotypes [45, 46]. Thus, extending the search 
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for neurobiological correlates relating to PLE may shed further light on the dopaminergic 
fronto-striatal pathway [47, 48] in nonclinical psychosis phenotypes [39, 49]. 
Building on previous studies [34, 36, 39], we replicate dimensional approaches using 
whole-brain voxel-wise analysis. Complementary regional analyses are based on 
primary outcomes to achieve robust targets relevant to the study cohort. The first aim of 
this investigation was to examine associations between PLE, PLE distress severity, and 
brain structure. We predict brain structural reductions in association with subclinical PLE 
and distress severity. Further, we explored the influence of the interaction of PLE and 
PLE related distress severity on regional brain volume.  
2. Methods 
2.1.Sample  
A total of 104 participants (71 females, 33 males; mean age=24.96, SD=4.76, min=18, 
max=40), all fluent speakers of the German language, were recruited from the local 
community using advertisements and the university email circulation service. The study 
procotol adhered to the Declaration of Helsinki[50] and was approved by the local ethics 
committee of the School of Medicine, Philipps-University of Marburg. Based on an initial 
telephone screening protocol, we obtained information on exclusion criteria: medical 
history (neurological or untreated chronic medical condition), past and current substance 
use, and any history of psychiatric or neurological disorders and treatments including 
psychotropic medication. Participants aged 18-40 years were then screened using the 
German version of the Structured Interview for DSM-IV [51]. Participants provided written 
informed consent once invited to complete brain scans and online questionnaires [52], 
and received financial compensation after participation. Mean laterality quotient of 
handedness [53] within this cohort was 71.91 (SD=62.07). An estimated intelligence 




2.2. Prodromal Questionnaire (PQ-16)  
We assessed PLE using the 16-item Prodromal Questionnaire (PQ-16)[6], a self-report 
measure to assess presence of PLE developed from prior versions [5, 7]. The validation 
of the 16-item version showed that a cutoff of ≥6 endorsed PLE identifies UHR states 
with 87% sensitivity and 87% specificity [6]. Complementary to the total sum of item 
endorsements on the 2-point scale (‘true’/’false’), a measure of distress severity for each 
endorsed item is obtained on a 4-point scale from 0 (‘none’) to 3 (‘severe’). In addition to 
the total symptom score, the distress severity scale cutoff score ≥9 was recommended 
in a study of non-help seeking subjects [55]. Based on previous psychometric studies [5, 
6, 23, 56] and guided by item comparison to the German version of the Structured 
Interview for Prodromal Syndromes Version 5.0 (SIPS) [17], we assigned items to two 
positive symptom subscales reflecting ‘Perceptual abnormalities/Hallucinations’ 
(Perceptual: items 3, 4, 5, 6, 8, 9, 12, 13, 15), ‘Unusual thought content/Delusional ideas’ 
(Delusional: items 2, 10, 11, 14, 16 ), and Negative symptoms (items 1 and 7) (Table 1). 
Table 2 displays Cronbach’s alpha as measures of internal consistency for these scales, 
and frequency of single item endorsements within this community sample is shown in 
Figure 1.  
2.3.MRI acquisition and voxel-based morphometry (VBM)  
We obtained high-resolution T1-weighted MRI using a 3.0-T Siemens Tim Trio scanner 
(Siemens, Erlangen, Germany) with standard 12-channel quadrature head coil and a 3D 
magnetisation-prepared rapid-acquisition gradient echo (MP-RAGE) sequence (4:26 
minutes; TE=2.26ms, TI=900ms, TR=1900ms, 1 mm3 isotropic voxel resolution). We 
then used the Computational Anatomy Toolbox for SPM (CAT12 v12.6, r1450, Christian 
Gaser, Structural Brain Mapping Group, Jena University Hospital, Germany in SPM12 
(v7219, Statistical Parametric Mapping, Wellcome Trust Centre for Neuroimaging, 
London, UK) for correction of homogeneity bias and segmentation of T1-weighted 
images into grey (GM) and white matter and cerebrospinal fluid. All images passed both 
visual inspection and CAT12 quality assessment protocols. Internal GM threshold was 
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set to 0.1 and scans were smoothed with a full width at half maximum Gaussian kernel 
of 8mm.   
2.4.  Statistical Analyses: General Linear Models 
Multiple linear regression models were conducted in SPM12 running in Matlab (R2017a, 
The Mathworks Inc., USA) to test associations between grey matter volume (GMV) and 
total PLE score and distress severity score, respectively. Age, sex, and total intracranial 
volume (TIV) were entered as control variables to these models. In these voxelwise 
volumetric analyses, the statistical threshold was set to p<0.05 applying false-discovery-
rate (FDR) peak-level correction. Anatomical labelling of maximum voxel coordinates 
was based on the DARTEL neuromorphometrics altas.  
2.5. Moderation Analyses 
Using the regions-of-interest tool within CAT12.5 (r1363), we extracted estimated mean 
GMV for each participant based on the neuromorphometrics atlas. These volumes of 
interest (VOI) were dependent variables in moderation analyses conducted in 
PROCESS 3.3 [57] for SPSS (Version 25.0, IBM Corp., Armonk, NY). Interactions of 
Total PLE×distress for Perceptual and Delusional distress severity were examined as 
estimators of VOI. Due to the low item and score range, we refrained from including 
Negative symptoms in moderation analyses. We corrected coefficient p-values for 
multiple comparisons for the number of dependent variables (VOI) for each PLE 
subscale using FDR adjusted p-values. FDR-corrections for multiple comparisons [58] 
were carried out in R [59]. 
3.Results 
3.1. PLE screening outcomes  
On average, at least one PLE (M=1.30, SD=1.78, scale score range=0-9) and a mean 
distress dimension score of 1.44 (SD=2.15, scale score range range=0-10) was reported 
in the present sample. Table 1 provides descriptive statistics for each PQ-16 item, the 
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three PLE subscales and correlations with the overall distress score with two-sided 
significance levels. Four participants met the clinical screening threshold (PQ-16 total 
score ≥6 and/or PQ-16 distress score ≥9) and were invited to a follow-up assessment for 
CHR status using Schizophrenia Proneness Instrument (SPI-A)[60]. Three participants 
completed the clinical interview; none met basic symptom criteria.  
Fig 1 Distribution of psychotic-like experiences (PLE) captured by the German version of the Prodromal Questionnaire 
16 (PQ-16) in 104 nonclinical subjects. Most PLE were assigned to three categories reflecting positive (Delusional, 
Perceptual) and Negative PLE based on a comparison to the Structured Interview for Prodromal Syndromes (SIPS). 
Note: Item descriptions are abbreviated for display purposes. This figure was created using ggplot2[94] 
 
3.2. VBM outcomes for PLE  
Total PLE score showed a significant positive association with volume in the right 
prefrontal region (cluster size k=246) with two significant peaks at the right superior 
(rSFG, maximum voxel coordinates X/Y/Z=18/−3/56, t=5.42, p=0.009) and middle frontal 
gyrus (rMFG) (maximum voxel coordinates X/Y/Z=30/2/52, t=5.97, p=0.005). PQ-16 
associations were significant at the FDR-corrected statistical threshold in the occipital 
fusiform and lingual gyri (k=45, X/Y/Z=22/−76/−14, t=4.73, p=0.019), in another small 
cluster in the rMFG (k=6, X/Y/Z=−34/22/45, t=4.40, p=0.031) and left precentral gyrus 
(k=1, X/Y/Z =−39/0/46, t=4.18, p=0.048) (all FDR-corrected p-values). Distress severity 
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showed no positive or negative relationship with GMV after FDR-correction for statistical 
significance.  
Table 1 Descriptive statistics of PLE in 104 healthy adults assessed by Prodromal 
Questionnaire (PQ-16) 
aSD = standard deviation 
br=Spearman correlation coefficient 




Prodromal Questionnaire (PQ-16) Total Scale Distress Scale 
 Mean SDa Mean SDa rb pFDRc 
PLE score  1.30 1.78 1.44 2.15 0.92 <0.001 
Perceptual abnormalities/Hallucinations 0.50 1.01 0.56 1.21 0.68 <0.001 
I sometimes smell or taste things that other people can’t smell or taste. 0.09 0.28 0.09 0.34 0.37 <0.001 
I often hear unusual sounds like banging, clicking, hissing, clapping or ringing in my ears. 0.07 0.25 0.08 0.39 0.33 0.001 
I have been confused at times whether something I experienced was real or imaginary. 0.04 0.19 0.06 0.31 0.31 0.001 
When I look at a person, or look at myself in a mirror, I have seen the face change right before my eyes. 0.02 0.14 0.02 0.14 0.22 0.026 
I have seen things that other people apparently can’t see. 0.02 0.14 0.02 0.14 0.24 0.019 
My thoughts are sometimes so strong that I can almost hear them. 0.12 0.32 0.14 0.51 0.37 <0.001 
Sometimes I feel suddenly distracted by distant sounds that I am not normally aware of. 0.10 0.30 0.10 0.33 0.39 <0.001 
I have heard things other people can’t hear like voices of people whispering or talking. 0.01 0.10 0.02 0.20 0.15 0.126 
I have had the sense that some person or force is around me, even though I could not see anyone. 0.05 0.21 0.04 0.19 0.36 <0.001 
Unusual thought content/Delusional ideas 0.59 0.89 0.65 1.10 0.75 <0.001 
I often seem to live through events exactly as they happened before (déjà vu). 0.23 0.42 0.26 0.61 0.47 <0.001 
I sometimes see special meanings in advertisements, shop windows, or in the way things are arranged around me. 0.12 0.32 0.12 0.43 0.48 <0.001 
Sometimes I have felt that I’m not in control of my own ideas or thoughts. 0.09 0.28 0.10 0.38 0.37 <0.001 
I often feel that others have it in for me. 0.13 0.34 0.18 0.50 0.45 <0.001 
I feel that parts of my body have changed in some way, or that parts of my body are working differently than before. 0.02 0.14 0.00 0.00 0.21 0.033 
Negative symptoms 0.21 0.43 0.23 0.58 0.47 <0.001 
I feel uninterested in the things I used to enjoy. 0.19 0.40 0.21 0.53 0.43 <0.001 
I get extremely anxious when meeting people for the first time. 0.02 0.14 0.02 0.14 0.25 0.015 
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Table 2 Reliability measures for subscales derived from the Prodromal-Questionnaire 
(PQ-16) 
aα=Cronbach’s alpha
PQ-16 Scale Min Max Skew Kurtosis αa 
Total PLE 0 9 1.84 3.65 0.69 
Total PLE Distress 0 10 1.77 2.79 0.58 
Perceptual Scale      
Total 0 5 2.79 8.48 0.62 
Distress 0 6 2.61 6.81 0.47 
Delusional Scale      
Total 0 4 1.51 1.84 0.46 
Distress 0 5 1.79 2.88 0.28 
Negative Scale      
Total 0 2 1.79 2.20 0.13 
Distress 0 3 3.01 10.00 0.18 
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3.3. Moderating effects of PLE distress severity  
The prefrontal VBM cluster showed two local maxima in the DLPFC, indicating the middle 
(rMFG) and superior frontal gyri (rSFG). For Delusional, no effect was observed in either rMFG 
or rSFG model. A moderating effect of Perceptual in the rMFG was only significant at trend-
level [unstandardized coefficient=−0.15, SE=0.08, t(97)=−1.90, pFDR=0.060], while the overall 
significant model for the rSFG [F(6,97)=22.06, p<0.001, R2=0.52] showed a significant 
moderation of Perceptual distress scores ≥2.75 [unstandardised coefficient=−0.09, SE=0.04, 
t(97)=−2.32, pFDR=0.044], with increased Perceptual distress resulting in decreased GM value 
(Table 3). Due to an overrepresentation of females, the additional nonsignificant moderating 
effect of sex on this pathway (i.e. PLE×Perceptual PLE distress×Sex interaction) was 
inspected with the PROCESS macro.  
 
Table 3 Regression models 
 
aSE=Cribari-Neto heteroskedasticity-consistent standard error  
bpFDR= p-value after false discovery rate (FDR) adjustment 
cLLCI= 95% lower (LLCI) and upper (ULCI) limit confidence interval 
  
 
  Perceptual PLE Delusional PLE 
  F(6,97)=22.06, p<0.001, R2=0.52 F(6,97)=19.17, p<0.001,    R2=0.51 
Dependent variable Predictor Coefficient (SE)a t p pFDRb LLCIc ULCIc Coefficient (SE)a t p pFDRb LLCIc ULCIc 
Superior frontal gyrus 
Intercept 2.85 (1.90) 1.50 0.137 0.274 −0.92 6.62 2.80 (1.98) 1.41 0.161 0.245 −1.14 6.73 
Sex 0.38 (0.33) 1.12 0.263 0.526 −0.29 1.04 0.38 (0.34) 1.09 0.277 0.554 −0.31 1.06 
Age −0.07 (0.02) −3.47 0.001 0.001 −0.11 −0.03 −0.07 (0.02) −3.24 0.002 0.002 −0.12 −0.03 
TIV 0.01 (0.00) 8.34 5×10-13 5×10-13 0.01 0.01 0.01 (0.00) 8.09 2×10-12 2×10-12 0.01 0.01 
Total PLE 0.07 (0.10) 0.69 0.493 0.493 −0.13 0.26 0.01 (0.13) 0.05 0.959 0.959 −0.25 0.26 
Distress 0.40 (0.18) 2.23 0.028 0.056 0.04 0.76 0.14 (0.24) 0.61 0.544 0.544 −0.33 0.62 
PLE×distress −0.09 (0.04) −2.32 0.022 0.044 −0.17 −0.01 −0.02 (0.05) −0.47 0.640 0.640 −0.13 0.08 
Middle frontal gyrus 
 Perceptual PLE Delusional PLE 
 F(6,97)=43.67, p<0.001,  R2=0.64 F(6,97)=37.17, p<0.001,  R2=0.66 
Predictor Coefficient (SE)a t p pFDRb LLCIc ULCIc Coefficient (SE)a t p pFDRb LLCIc ULCIc 
Intercept 2.57 (2.78) 0.92 0.358 0.358 −2.95 8.09 3.39 (2.90) 1.17 0.245 0.245 −2.36 9.13 
Sex −0.18 (0.45) −0.39 0.700 0.700 −1.08 0.72 −0.26 (0.45) −0.57 0.572 0.572 −1.15 0.64 
Age −0.11 (0.04) −3.28 0.001 0.001 −0.18 −0.05 −0.13 (0.04) −3.59 0.001 0.002 −0.20 −0.06 
TIV 0.01 (0.00) 9.56 1×10-15 2×10-15 0.01 0.02 0.01 (0.00) 9.01 2×10-14 4×10-14 0.01 0.02 
Total PLE 0.19 (0.16) 1.21 0.231 0.462 −0.12 0.51 0.40 (0.39) 1.04 0.303 0.606 −0.37 1.17 
Distress 0.52 (0.31) 1.70 0.093 0.093 −0.09 1.13 0.43 (0.51) 0.85 0.396 0.544 −0.57 1.44 




Fig 2  Upper panel shows statistical significance (thresholded at FDR-corrected p<0.05) and effect size (thresholded at 
uncorrected peak-level p<0.001) maps for structural correlates of total psychotic-like experiences (PLE), assessed by the 
Prodromal Questionnaire (PQ-16). Mean volumes of interest (VOI) were extracted from two prefrontal regions: right superior 
(rSFG) and middle frontal gyri (rMFG), which enclose the largest cluster of size k=246.  Lower panel shows the effect of distress 
and PLE interaction on predicted rSFG volume. At higher Perceptual PLE distress severity (scale score ≥2.75), overall PLE are 
associated with predicted rSFG volume reductions. This figure was created using MRIcroGL 





4. Discussion   
The present study aimed to elucidate the relationship between brain structure and PLE in 
nonclinical subjects devoid of attenuated risk for psychosis. The results revealed a positive 
association between PLE and volume in right dorsolateral prefrontal, fusiform and occipital 
brain regions, which was not present for the distress severity scale. However, exploratory 
analysis of the whole right superior and middle frontal gyral volumes showed a modulating 
effect of distress severity. 
The main finding of this study is that PLE applicable for psychosis risk screening are associated 
with neurobiological changes independent of UHR case-control status, conversion [61], and 
UHR phenotype heterogeneity (e.g., genetic risk deterioration syndrome, attenuated psychotic 
syndrome, brief limited intermittent psychotic symptoms) [62]. Correlates for subclinical PLE 
were detected in the right hemisphere. This differs from clinical findings in schizophrenia, 
showing either left lateral or bilateral GM reductions in the medial and superior temporal lobes 
[63, 64] and a linkage with severity of auditory hallucinations [65]. However, GM alterations in 
the right dorsolateral prefrontal cortex are also represented in studies of schizophrenia and 
diverse prodromal stages [63, 66–69]. Regional GM differences between healthy, genetic-high 
risk, and first-episode schizophrenia individuals also highlight genetic components [70]. Our 
significant regional findings align with some of those found in the genetic-high risk group in 
Chang et al.[70], such as larger volumes in rMFG and fusiform gyrus compared to healthy 
controls. Interestingly, a large genome-wide association study recently demonstrated shared 
genetic liability between PLE and multiple psychiatric conditions [71].  
Magnitude of GMV loss shows some variability over disease progression [72], and progressive 
structural differences were also seen in reduced white matter growth in UHR adolescents [73]. 
Accelerated prefrontal GMV loss may indicate differential pathological processes at different 
neurodevelopmental stages in schizophrenia [74]. This would be in line with potentially non-
linear patterns of brain structural changes dependent on transition and illness phase [75].  
However, another comparison of CHR youths to controls could not confirm structural and 
cortical thickness differences regardless of later transition to psychosis [76]. In that study, the 
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critical role of sample uniqueness, especially the absence of illicit drug use, including cannabis, 
are discussed. An extension of our design would be an exploration of the effect of illicit drug 
use on the observed PLE-brain structural relationship.  
Contrary to predictions, we found a positive direction for the association between PLE and 
GMV. In the earlier analysis [39], positive schizotypal traits were associated with GMV 
reductions in superior and middle frontal gyri. Tact-based white matter and GMV analyses 
implicated alterations in fronto-striatal network regions in schizotypy. However, it remains 
speculative whether all schizotypy dimensions equally reflect neural deficits or vulnerability. 
The proximity between PLE and positive schizotypy is further supported by their anatomical 
overlap, however, PLE correlated with larger volumes in a prefrontal cluster. Together the 
findings from these two studies do not support a linear continuum ranging from the subclinical 
phenotypes to CHR and schizophrenia spectrum disorders [31, 77].  
The right superior and middle frontal gyri, which are cortical correlates in CHR and transition 
status [26, 78], could imply modulation by intraindividual psychological factors that may convey 
vulnerability or resilience in nonclinical individuals, too. Larger DLPFC volumes may be 
explained by compensatory mechanisms, e.g., in response to upstream striatal alterations [77]. 
Compensatory processes were also proposed for larger precuneus and posterior cingulate 
cortex volumes in association with nonclinical psychosis proneness [34, 79, 80], despite 
volume reductions in the clinical spectrum being common [68, 81, 82].  In that case, larger 
regional prefrontal volumes at higher PLE levels, but reductions related to the interaction of 
overall PLE and distress severity of perceptual anomalies, may indicate attenuated protective 
features. This buffering explanation was earlier proposed by Meller et al. [49], showing that the 
association between positive schizotypy and larger striatal volume is decreased by general 
intelligence (a functional substrate of the frontal regions). Preservation of prefrontal functions 
and GMV [83] may be pivotal determinants of clinical deterioration and prevention. A 
comparison of brain developmental trajectories in resilient and non-resilient UHR youths found 
larger frontal volumes over time in the higher functioning group [27]. Resilience [84] may 
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contribute to prefrontal cortical variation in nonclinical subjects as well. This would be in 
keeping with the notion that PLE are manifestations of the positive schizotypy dimension [43], 
which correlates with psychosis-relevant genotypes involved in dopamine regulation [45]. A 
specific effect for the perceptual PLE component also fits in with the striatal dopamine 
hypothesis underlying psychosis in schizophrenia and general psychosis proneness [47].  
Additionally, the right occipital fusiform and lingual regions were positively associated with 
PLE. This finding in the occipitotemporal region indicates unique PLE correlates that were not 
present in multidimensional schizotypy. Involvement of the fusiform gyrus in perception and 
face recognition [85, 86], together with occipitotemporal GMV reductions in schizophrenia and 
psychosis [87–89], underpins deficits related to facial processing in the clinical spectrum [90]. 
One PQ-16 item (‘When I look at a person, or look at myself in a mirror, I have seen the face 
change right before my eyes’) may have been especially relevant to the diametrically opposed 
outcome in nonclinical individuals. Another study reported associations between positive PLE 
distress and precuneus volume, which were not present in trait psychosis proneness [38]. Our 
findings for a positive association for PLE load located in the dorsolateral cortical regions as 
opposed to parietal brain regions may be explained by differences between purely quantitative 
PLE levels, and measures relating to the qualitative burden of PLE. Failure to replicate 
precuneus correlates for PLE distress in the present study may be attributed to differing 
psychometric PLE measures related to different aspects of psychosis proneness. Nonetheless, 
they complement each other in that they underline the impact of perceiving positive symptoms 
as worrisome in brain regions implicated across the psychosis spectrum.  
Some limitations of this study require evaluation. Although the present cohort consists of young 
adults, we must acknowledge that cross-sectional designs do not permit prediction of 
subsequent psychopathological development. Another inherent problem of studies with 
nonclinical designs is a non-normal PLE distribution [e.g. 91]. Also, the size of the study cohort 
was limited, which might have hampered the detection of smaller effects. Adoption of 
instrument (long vs. short PQ versions), setting, and UHR enrichment are sources of detection 
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threshold variability [13]. Self-reported PLE are poor measures of clinician-rated psychosis risk 
[15], and current recommendations state clinical CHR assessment should only be extended to 
those distressed by symptoms [1]. Note also that symptom dimensions were based on the 
assessment of item contents but require validation using factor analysis. This is especially 
recommended for positive items where the latent delusional or perceptual character is 
ambiguous. Brandizzi and colleagues’ [23] analysis of PQ-92 positive items yielded factors 
reflecting ‘perceptual abnormalities’, ‘bizarre experiences’, as well as ‘conceptual 
disorganisation and suspiciousness’ and ‘magical ideation’ also found in schizotypy. 
Additionally, Kotzalidis et al. [56] identified a four-factor solution, including a heterogenous 
‘functional’ dimension. While this provides options for replication using the extended versions 
of the Prodromal Questionnaire, the translation of these factors to the 16-item screening 
inventory seems unlikely.  
While further replication in larger samples is warranted, our findings go beyond symptom-
structure associations by showing the moderating impact of the distress dimension on the 
anatomical underpinnings of PLE. This posits a crucial distinction for future dimensional model 
studies as the marked distinction between (positive) subclinical symptoms with varying 
degrees of subjective impact is stressed. It is currently expected that neuroimaging studies will 
provide complementary tools for predicting transition to psychosis [92] and long-term clinical 
outcomes [93]. Our study supports these attempts by isolating the neurobiological uniqueness 
of PLE in the nonclinical part of the psychosis spectrum. We suggest that future investigations 
might also address the neurobiological characterisation of resilience in genotypes and 
phenotypes related to psychosis proneness.  
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Background: Schizotypy and psychotic-like experiences (PLE) form part of the wider 
psychosis continuum and may have brain structural correlates in nonclinical cohorts. This 
study aimed to compare the effects of differential schizotypy dimensions, PLE, and their 
interaction on hippocampal subfields and amygdala volumes in the absence of clinical 
psychopathology. Methods: In a cohort of 367 psychiatrically healthy individuals, we assessed 
schizotypal traits using the Oxford-Liverpool Inventory of Life Experiences (O-LIFE), and PLE 
using the short form of the Prodromal Questionnaire (PQ-16). Based on high-resolution 
structural MRI scans, we used automated segmentation to estimate volumes of limbic 
structures. Sex and total intracranial volume (step 1), PLE and schizotypy dimensions (step 
2), and their interaction terms (step 3), were entered as regressors for five bilateral 
hippocampal subfield and amygdala volumes in hierarchical multiple linear regression models. 
Results: Positive schizotypy, but not PLE, was negatively associated with left amygdala and 
subiculum volumes. O-LIFE Impulsive Nonconformity, as well as the two-way interaction 
between positive schizotypy and PLE were associated with larger left subiculum. None of the 
estimators for right hemispheric hippocampal subfield volumes survived correction for multiple 
comparisons. Conclusions: Our findings support differential associations of hippocampus 
subfield volumes with trait dimensions rather than PLE, and support overlap and interactions 
between psychometric positive schizotypy and PLE.  In a healthy cohort without current 
psychosis risk syndromes, the positive association between PLE and hippocampal subfield 
volume occurred at a high expression of positive schizotypy. Further studies combining stable, 
transient, and genetic parameters are required.  
 




Psychotic-like experiences (PLE) signify psychosis risk, yet only a considerably small portion 
of persons reporting such transient expressions of psychosis proneness will go on to develop 
a psychotic disorder (Linscott & van Os, 2013). PLE are elevated in individuals displaying 
schizotypal traits, which are behavioural, emotional and cognitive characteristics resembling 
the core symptoms of psychotic disorders along a health-illness spectrum (Claridge & Beech, 
1995; Grant, Green, & Mason, 2018; Kwapil & Barrantes-vidal, 2015). Schizotypy 
encompasses the positive, negative, and disorganised dimensions (Debbané & Barrantes-
Vidal, 2015) found in psychotic disorders, with each trait dimension showing differential 
associations with psychopathology (Kwapil, Gross, Silvia, & Barrantes-Vidal, 2013), affective 
states (Kemp, Gross, Barrantes-Vidal, & Kwapil, 2018), and perceptual and cognitive 
outcomes (Ettinger, Meyhöfer, Steffens, Wagner, & Koutsouleris, 2014; Ettinger et al., 2015). 
This highlights the multifaceted nature of schizotypy and its value in the detection of clinical 
high risk (CHR) states (Barrantes-Vidal, Gross, et al., 2013; Flückiger et al., 2016). For 
example, increased PLE levels are especially observed in positive schizotypy (Barrantes-Vidal, 
Chun, Myin-Germeys, & Kwapil, 2013; Kwapil et al., 2020), as well as depression and anxiety 
(Varghese et al., 2011), demonstrating that the emergence of psychopathology, PLE and 
schizotypal traits are intertwined in a dynamic fashion (Barrantes-Vidal, Grant, & Kwapil, 2015). 
The fully dimensional conceptualisation of schizotypy also accounts for the non-pathological 
phenotypes (Nelson, Seal, Pantelis, & Phillips, 2013), such as 'benign schizotypes' 
characterised by high positive schizotypy, but low negative and disorganised traits (Mohr & 
Claridge, 2015). Hence, the positive schizotypy facet (together with low negative and 
disorganised facets) is related to higher PLE levels independently of induced stress states 
(Grant & Hennig, 2020), while the emergence of distressing PLE outside of familiar positive 
traits may convey increased psychosis vulnerability (Debbané & Barrantes-Vidal, 2015). The 
positive relationship between trait schizotypy and PLE is matched by PLE distress reduction 
as a function of schizotypy in nonclinical subjects (Kline et al., 2012), supporting a schizotypal 
context for PLE rooted in health or resilience.  
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Previous studies demonstrated that trait schizotypy and PLE correlate with cortical changes in 
areas consistently observed in clinical psychosis. They found brain structural (Ettinger et al., 
2012; Meller et al., 2020; Modinos et al., 2010; Pfarr & Nenadić, 2020) and cortical surface 
variability (Evermann, Gaser, Besteher, Langbein, & Nenadić, 2020) associations with these 
phenotypes. These findings suggest that subclinical psychosis prone phenotypes show brain 
correlates in regions affected clinical psychosis, which are not necessarily a sign of 
vulnerability but could also indicate compensatory processes (Kühn, Schubert, & Gallinat, 
2012; Mohr & Claridge, 2015). Investigating replicated brain regions involved in psychosis 
pathophysiology may facilitate the demarcation of vulnerable or disease progressive states.  
Abnormalities of medial temporal lobe hippocampal (HC) and amygdala structures 
observed in schizophrenia (van Erp et al., 2016), propose neuroanatomical targets for 
psychosis spectrum research (Lieberman et al., 2018). Hippocampal subfield analyses point 
to volume reductions in the cornu ammonis (CA) and dentate gyrus (DG) sections (Haukvik, 
Tamnes, Söderman, & Agartz, 2018; Nakahara, Matsumoto, & van Erp, 2018), which are 
paralleled by functional studies indicating CA1 and possibly also subiculum hyperactivity 
(operationalised as increased cerebral blood volume) in patients (Schobel et al., 2013, 2009; 
Talati et al., 2014). Volume reductions in total hippocampal volume and subfields might already 
be present at disease onset (Briend et al., 2020) and, more importantly, already at CHR stages 
preceding disease onset (Ganzola, Maziade, & Duchesne, 2014; Wood et al., 2010), although 
findings are not entirely consistent across cohorts (for a review see Walter et al., 2016).  
Post mortem studies in schizophrenia show differential involvement of CA1, CA3, and 
DG subfields (Bobilev, Perez, & Tamminga, 2020; Perez et al., 2020), which is supported by 
differential associations between HC segments and positive and negative clinical symptoms in 
in vivo studies. Left CA2/3 and CA4/DG (Kawano et al., 2015) and subiculum (Haukvik et al., 
2015) volumes show inverse associations with negative symptom severity in schizophrenia. 
Further studies report CA1 and CA2/3 (Kühn et al., 2012) and subiculum (Mathew et al., 2014) 
volume deficits in association with positive symptoms of psychosis. Mathew et al. (2014) found 
negative correlations between positive symptoms and hallucinations scale scores based on 
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the Positive and Negative Syndrome Scale (PANSS, Kay, Fiszbein, & Opler, 1987) for 
schizophrenia and CA4/DG, presubiculum, subiculum, and whole HC volumes. These 
pathological medial temporal changes appear to be exaggerated in the left hemisphere 
(Velakoulis et al., 2006; Wood et al., 2010). 
In addition to abnormalities reported in frank psychosis, examinations of HC volumes 
as potential biological markers have emerged in the nonclinical part of the psychosis spectrum, 
too. A developmental study demonstrated flattened bilateral hippocampal volume trajectories 
in adolescents with elevated psychometric disorganised schizotypy (Derome et al., 2020).  
Recently we reported that HC subfields are indeed altered by the interaction of negative and 
disorganised schizotypy dimensions, which predicted volumetric reductions in anterior and 
whole left HC (Sahakyan et al., 2020). Structural effects in schizotypy and ultra-high risk (UHR) 
states are also paralleled by functional alterations, such as augmented right hippocampal 
perfusion in high positive schizotypy (Modinos et al., 2018) and increased hippocampal 
perfusion in UHR (Allen et al., 2018, 2015; Bossong et al., 2019).  Hypermetabolism spreading 
from the CA1 subregion could explain gradual hippocampal atrophy (Schobel et al., 2013, 
2009).   
Besides detailed volumetry of HC subfields, contemporary automated segmentation 
methods also provide high-resolution structural delineation of the amygdala. In the wider limbic 
system, similar investigations show bilateral whole amygdala volume reductions in first-
episode psychosis (FEP) (Watson et al., 2012), as well as smaller amygdala subnuclei in CHR 
and FEP (Armio et al., 2020).  Superimposed organisational patterns suggest demarcated 
ventral HC (CA1 and subiculum) connectivity with the amygdala (Strange, Witter, Lein, & 
Moser, 2014). Emotion recognition is a functional amygdala substrate showing alterations in 
schizophrenia (Mier et al., 2014), adolescents at UHR (Bartholomeusz et al., 2014), and 
schizotypy (Statucka & Walder, 2017; Wang et al., 2018). Another study reported a significant 
negative relationship between blunted affect and left amygdala activation in schizophrenia 
patients during positive affect processing (Rahm et al., 2015). Additionally, asymmetric 
amygdalar surface volumes in CHR with violent ideation (Feng et al., 2019) implicates a 
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relationship with aggression and impulsivity. Thus, investigating amygdala volumes as an 
extension of the longitudinal HC axis may be a valuable addition to existing studies.  
The present study aims to explore interactions between continuous schizotypal traits 
and PLE in a general population cohort in association with HC subfields and amygdala 
volumes.  We hypothesise that medial temporal lobe structures show differential associations 
with schizotypy dimensions and PLE, as well as their interaction. Based on previously 
described patterns of volume reductions in incipient and early psychosis patients, we predict 
that positive schizotypy and PLE are associated with left CA1 volume reduction. Further, we 
expect positive and negative schizotypy to associate with subiculum, CA2/3 and CA4/DG 
volume reductions, and amygdala volume to vary as a function of impulsive and negative 
schizotypy. Based on a previous report (Sahakyan et al., 2020), we predict that interactions 
between PLE and schizotypy dimensions are associated with left medial temporal lobe 
structural decreases.   
Methods 
Study cohort 
This study included 367 German language proficient individuals (aged 18 to 40) from the 
general community, volunteering in response to university-based email circulation, local and 
online advertisements. Participants were screened by phone using Structured Clinical 
Interview for DSM-IV (Wittchen, Wunderlich, Gruschwitz, & Zaudig, 1997), and selected for 
study inclusion if no history of mental health, neurological or chronic medical conditions were 
present. This study protocol was in agreement with the Declaration of Helsinki (World Medical 
Association, 2013) and approved by the local ethics committee of the Medical School of the 
Philipps-University of Marburg. Participants provided written informed consent, completed 
phenotype self-report measures online, and received financial compensation upon study 
completion. Overall, 383 participants were initially scanned. Following exclusion of 16 
individuals due to insufficient T1-image quality or incompleteness of survey data, full 
phenotyping and HC volume estimates were available from 367 [238 (64.85%) females, 129 
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males (35.15%)] healthy adults (Mean age= 23.85, SD=3.75 years, min=18, max=39) included 
in the analysis. In this study, we extended the sample previously described in Sahakyan et al. 
(2020). Seven (1.91%) participants scored PLE equal to or above the CHR screening criteria 
applied in previous studies (Chen et al., 2016; Ising et al., 2012). CHR was ruled out in all four 
out of seven (51.14%) participants who also agreed to follow-up assessments with 
Schizophrenia Proneness Instrument (Adult version) (Schultze-Lutter, Addington, Ruhrmann, 
& Klosterkötter, 2007). The mean laterality quotient according to the Edinburgh Handedness 
Inventory (Oldfield, 1971) was 78.65 (SD=53.22), and mean IQ estimated by the 
Mehrfachwahl-Wortschatz-Test B (Lehrl, 2005) was 116.38 (SD=14.02, min=92, max=145). 
Imaging data acquisition and preprocessing 
T1-weighed brain images were obtained with a 3-T Siemens Tim Trio magnetic resonance 
scanner (Siemens, Erlangen, Germany) using a 12-channel quadrature head coil and 
MPRAGE sequence with a duration of 4:26 minutes (TE=2.26ms, TI=900ms, TR=1900ms). 
Homogeneity bias correction and tissue segmentation were conducted using Computational 
Anatomy Toolbox for SPM, (CAT12.7, r1598, Gaser, Dahnke, Kurth, & Luders, 2020) in 
SPM12 (version 12, v7771, Statistical Parametric Mapping, Wellcome Trust Centre for 
Neuroimaging, London, UK) running in Matlab (R2017a, The Mathworks Inc). Hippocampal 
regions of interest volumes were estimated in unsmoothed native grey matter images.  
Assessment of trait schizotypy 
Schizotypal traits were measured using the German version of the Oxford-Liverpool Inventory 
of Feelings and Experiences (O-LIFE, Mason, Claridge, & Jackson, 1995). Based on 104 items 
the O-LIFE measures scores on four individual dimensions, which reflect the heterogeneous 
positive (UnEx), negative (IntAn), disorganised (CogDis) as well as behaviourally odd 
(ImpNon) facets of schizotypy. UnEx corresponds to perceptual anomalies and magical 
thinking, while CogDis taps into attention and thought aberrances reflecting disorganised 
symptoms of psychosis. The IntAn dimension measures anhedonic phenomena related to 
social and physical activities, and ImpNon refers to impulsive and socially non-conforming 
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behaviour (Mason & Claridge, 2006; Mason et al., 1995). Descriptive statistics of sample 
characteristics and dimensional internal consistencies are shown in Table 1. 
Assessment of Psychotic-like experiences (PLE) 
PLE were assessed using the 16-item version of the Prodromal Questionnaire (PQ-16) (Ising 
et al., 2012), which provides a total PLE score on a two-point scale (answers' true' =1,' 
false'=0), and a measure of distress severity induced by PLE ('none' =0 to 'severe' =3). Cut-off 
scores of 6 on the total PLE scale and 9 on the distress scale have been identified as sufficient 
detection criteria for psychosis proneness (Chen et al., 2016; Ising et al., 2012). All 
questionnaires were completed online (www.soscisurvey.de, Leiner, 2019) and inspected for 
PLE above the recommended screening cut-off after study completion. 
Hippocampal subfield volume estimation and extraction 
We selected six bilateral limbic regions that were of a priori interest. These included the HC 
subfields labelled subiculum, cornus ammonis (CA)1, CA2/3, CA4/dentate gyrus (DG), 
SR/SL/SM [stratum radiatum (SR), stratum lacunosum (SL), stratum moleculare (SM)] as well 
as the whole amygdala. We used the novel segmentation tool implemented in CAT12.7, which 
uses the CoBra (Computational Brain Anatomy Laboratory at the Douglas Institute, Verdun, 
Canada) atlas (Winterburn et al., 2013) based on high-resolution (1 mm isotropic voxel size) 
images of HC subfields and amygdala (manual segmentation described in Entis, Doerga, 
Feldman, & Dickerson, 2012; atlas described in Treadway et al., 2015). Figure 1 displays 
subfield segmentations and Table 4 shows summarised average volumes across all subjects. 
Merging HC subfields, such as CA2/3, into a single label circumvents reliability issues related 
to particularly small subfields sizes. This offers a robustness advantage when anatomical 




Statistical analysis  
Phenotype associations with amygdala and hippocampal subfield volumes  
HC and amygdala volumes were analysed with hierarchical linear regression models in R 
(Version 3.6.3, R Core Team, 2020). We conducted 12 separate models, using the six bilateral 
volumes as dependent variables. Two-tailed Spearman correlations between subfield volumes 
and variables sex and total intracranial volume (TIV) (all p' s<0.05) were significant but 
insignificant for age (all p' s>0.05). Sex and TIV were entered at the first step for the covariate 
models. In the second step, trait schizotypy dimensions (UnEx, CogDis, IntAn, ImpNon) and 
PLE (PQ-16) scores were entered simultaneously (main effects models), followed by the 
phenotype interaction terms of PLE×schizotypy dimension in the third step. We standardised 
dependent and independent variables, compared models using analysis of variance (ANOVA), 
and examined two-way interactions using the Johnson-Neyman method through the 
PROCESS macro (Hayes, 2018). Since phenotype scales correlated (Table 1), 
multicollinearity at each step was controlled for by observation of variance inflation factor (>5 
criterion) and tolerance (<0.1 criterion) using the olsrr package (Hebbali, 2020) in R. Since we 
did not have an a priori hypothesis for right hemispheric subfields, we applied false detection 





In our analysis of the differential effects of trait schizotypy and PLE on HC subfield volumes, 
we observed significant effects for single schizotypy dimensions as well as a two-way 
interaction among trait and PLE scales. To facilitate comparisons between scales, we report 
standardised regression coefficients (β) with their individual p-values (Table 2). 
The main effect of positive schizotypy (UnEx) showed a significant association with left 
amygdala and subiculum volume reductions (Table 3). ImpNon was also positively associated 
with left subicular volume. The main effect of negative schizotypy (IntAn) emerged at trend-
level significance (p=0.073) in the left amygdala (Table 2). We did not find any effect of the 
CogDis dimension on HC subfield volumes, and model regressors of right hemispheric HC 
subfield models did not survive FDR-correction. 
Left subiculum subfield volume increase was associated with the two-way interaction of 
positive schizotypy and PLE, which significantly explained volume variability beyond main 
effects (Table 3b). Examination of regression slopes showed that PLE levels were significantly 
associated with a predicted subiculum volume increase at higher positive schizotypy levels. 
This moderation effect occurred in high positive schizotypy (observed UnEx score≥6.95 
equalling UnExmean +2.07×SD) (Figure 1). Based on the two-way interaction's significance 
interval, we used UnEx≥6.95 as a cut-off to conduct an exploratory subgroup comparison of 
state and trait profiles (Figure 1). The high positive schizotypy subgroup (n=20) showed 
significantly higher trait levels in all other schizotypy facets, PLE, and PLE associated distress 
(supplementary table 1). An interaction between PLE and positive schizotypy showed a trend 
(p=0.077) for an association with CA1 volume increase. UnEx and PLE showed the largest 
correlation in our sample (r=0.54, p<0.001). Hence the possibility of a covert non-linear 
association was explored with a polynomial regression model, exchanging the interaction term 




Table 1. Descriptive statistics of psychotic-like experiences (PLE) and schizotypy dimensions 
with Spearman correlation coefficients. 
O-LIFE=Oxford-Liverpool Inventory of Life Experiences, PQ-16= Prodromal Questionnaire, UnEx =Unusual Experiences, 








TIV= Total intracranial volume, UnEx (UE)= Unusual Experiences, CogDis (CD)=Cognitive Disorganisation, IntAn 
(IA)=Introvertive Anhedonia, ImpNon (IN)=Impulsive Nonconformity, PLE=Psychotic-like experiences. Bold face indicates 
significance at p<0.05, *False discovery rate-adjusted p-value 
 
  
 Mean SD Min Max Skew Kurtosis UnEx CogDis IntAn ImpNon Total Crobach’s α 
O-LIFE 
Scale             
UnEx 1.86 2.46 0 16 2.31 7.16  0.45** 0.08 0.33** 0.60** 0.75 
CogDis  5.21 4.31 0 21 0.96 0.56   0.35** 0.19** 0.81** 0.84 
IntAn  4.06 3.51 0 19 1.59 3.02    0.02 0.58** 0.77 
ImpNon  6.10 2.88 0 15 0.44 0.09     0.53** 0.58 
Total 17.23 8.69 3 54 0.88 0.82      0.85 
PQ-16             
PLE 1.08 1.51 0 9 1.97 4.88 0.54** 0.46** 0.11* 0.30** 0.52** 0.62 
PLE 
Distress 1.17 1.89 0 15 2.66 10.59 0.52** 0.45** 0.10* 0.29** 0.51** 0.60 
 
 
Step 1 Step 2 Step 3 
 
Covariates O-LIFE Dimension PQ-16 2-way interactions 
 
Sex TIV UnEx CogDis IntAn ImpNon PLE Score PLE × UE PLE × CD PLE × IA PLE × IN 
 
β p β p β p β p β p β p β p β p β p β p β p 
Left Hemisphere 
                      
Amygdala -0.197 0.000 0.599 0.000 -0.109 0.029 0.063 0.172 -0.071 0.073 0.061 0.135 0.077 0.130 0.012 0.582 0.000 0.991 -0.002 0.945 -0.008 0.824 
CA1 -0.007 0.880 0.662 0.000 -0.036 0.510 0.009 0.862 -0.038 0.377 0.079 0.073 0.032 0.566 0.040 0.077 -0.020 0.534 0.019 0.599 0.045 0.259 
CA2/3 -0.042 0.449 0.392 0.000 0.030 0.648 -0.054 0.378 0.023 0.659 0.030 0.577 0.045 0.501 -0.024 0.383 -0.039 0.324 0.002 0.964 -0.027 0.586 
CA4/DG -0.027 0.586 0.593 0.000 -0.020 0.725 0.009 0.864 -0.033 0.472 0.076 0.106 0.027 0.641 0.020 0.400 -0.029 0.391 -0.003 0.930 0.009 0.826 
Subiculum 0.001 0.979 0.728 0.000 -0.112 0.024 0.058 0.201 -0.052 0.186 0.088 0.030 0.051 0.307 0.053 0.011 0.015 0.617 0.014 0.669 0.022 0.547 
SR/SL/SM -0.052 0.260 0.638 0.000 -0.063 0.247 0.013 0.797 -0.042 0.330 0.064 0.146 0.075 0.172 0.017 0.454 -0.028 0.385 0.005 0.884 0.021 0.604 
Right Hemisphere 
                     
Amygdala -0.168 0.000* 0.644 0.000* -0.089 0.299* 0.067 0.763* -0.069 0.174* 0.087 0.156* 0.013 0.952* 0.001 0.970* -0.008 0.780* -0.002 0.940* -0.021 0.943* 
CA1 -0.044 0.661* 0.588 0.000* -0.012 0.903* 0.019 0.862* -0.061 0.216* -0.006 0.981* 0.004 0.952* 0.001 0.970* -0.021 0.780* -0.037 0.669* -0.003 0.943* 
CA2/3 -0.021 0.688* 0.502 0.000* 0.019 0.903* -0.010 0.862* -0.071 0.216* -0.016 0.981* -0.016 0.952* -0.032 0.664* -0.027 0.780* -0.073 0.468* -0.021 0.943* 
CA4/DG -0.044 0.661* 0.608 0.000* -0.007 0.903* 0.026 0.862* -0.080 0.174* 0.011 0.981* -0.012 0.952* -0.009 0.970* -0.028 0.780* -0.047 0.631* -0.018 0.943* 
Subiculum -0.025 0.661* 0.725 0.000* -0.081 0.299* 0.049 0.834* -0.042 0.275* 0.068 0.265* 0.042 0.952* 0.033 0.664* -0.008 0.780* 0.008 0.940* 0.003 0.943* 
SR/SL/SM -0.028 0.661* 0.649 0.000* -0.040 0.903* 0.034 0.862* -0.074 0.174* -0.001 0.981* 0.024 0.952* -0.003 0.970* -0.025 0.780* -0.023 0.784* -0.015 0.943* 
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Table 3. Summary of regression models predicting volume of the left amygdala and 
subiculum.  
 
TIV= Total intracranial volume, UnEx= Unusual Experiences, CogDis=Cognitive Disorganisation, IntAn=Introvertive Anhedonia, 
ImpNon=Impulsive Nonconformity, PLE=Psychotic-like experiences, R2 = adjusted R2, SE= Standard error, ***p<0.001, 
**p<0.01, *p<0.05 
 
Table 4. Means and standard deviations (SD) for left and right hemispheric subfield volumes.  
 Mean volume (SD) (mm3)  
Left hemisphere Right hemsiphere 
Amygdala 1733.22 (186.06) 1733.30 (180.93) 
CA1 1016.14 (107.16) 1074.99 (118.91) 
CA2/3 208.21 (29.01) 236.46 (30.55) 
CA4/DG 728.15 (79.10) 731.99 (82.62) 
Subiculum 512.98 (56.91) 537.91 (59.56) 
SR/SL/SM 548.60 (58.76) 562.14 (64.55) 
CA= cornu ammonis, DG=Dentate gyrus, SR=stratum radiatum, SL=stratum lacunosum (SL), SM=stratum moleculare. 
  
 Table 3a Table 3b 
 Left Amygdala  Left Subiculum 
 Step 1 
(Covariates) 
Step 2 (Main 
effects) 




Step 2 (Main 
effects) 
Step 3 (2-way 
interaction) 
 β SE β SE β SE β SE β SE β SE 
Intercept 0.000 0.036 0.000 0.036 −0.008 0.039 0.000 0.036 0.000 0.036 −0.035 0.038 
Sex −0.197*** 0.043 −0.199*** 0.045 −0.197*** 0.046 0.001 0.042 0.011 0.045 0.022 0.045 
TIV 0.599*** 0.043 0.597*** 0.043 0.599*** 0.043 0.728*** 0.042 0.726*** 0.042 0.737*** 0.042 
UnEx   −0.109* 0.050 −0.124* 0.057   −0.112* 0.049 −0.179** 0.056 
CogDis   0.063 0.046 0.068 0.047   0.058 0.045 0.085 0.046 
IntAn   −0.071 0.039 −0.073 0.040   −0.052 0.039 −0.060 0.039 
ImpNon   0.061 0.041 0.064 0.041   0.088* 0.040 0.104* 0.040 
PLE   0.077 0.051 0.065 0.055   0.051 0.050 −0.002 0.054 
PLE×UnEx     0.012 0.021     0.053* 0.021 
df 2, 364 7, 359 8, 358 2, 364 7, 359 8, 358 
R2 0.518 0.526 0.525 0.526 0.535 0.542 
∆R2  0.015 0.000  0.015 0.008 
F 197.566*** 59.022 51.583 204.233*** 61.061 55.077 




Figure 1  Visualisation of hippocampal subfield and amygdala segmentation using CoBra atlas (Winterburn et al., 2013) 
implemented in Computational Anatomy Toolbox (CAT12.7, Gaser et al., 2020) (top panel). Prediction of left subicular volume by 
psychotic-like experiences [assessed by Prodromal Questionnaire (PQ-16)] is  moderated by high levels of positive trait schizotypy 
(scores ≥6.95) as measured by the Unusual Experiences (UnEx) scale of the Oxford-Liverpool Inventory of Life Experiences (O-
LIFE) (bottom left). Bottom right side displays mean (±1 standard error) levels of negative (IntAn), disorganised (CogDis), impulsive 
(ImpNon) traits, PLE and PLE distress severity in a subgroup (n=20) with positive schizotypy levels ≥6.95 compared to the rest of 
the sample (n=347). Bar graphs show statistically significant group differences based on the Mann-Whitney U test.  CA= cornu 
ammonis, DG= dentate gyrus, SR=stratum radiatum, SL=stratum lacunosum (SL), SM=stratum moleculare. Figures were 
prepared using 3D Slicer (https://www.slicer.org)  , MRIcroGL (https://www.mccauslandcenter.sc.edu/mricrogl/) , ggplot2 





The aim of this study was an investigation of state and trait psychosis prone phenotypes within 
the nonclinical section of a putative psychosis spectrum of neurobiological abnormalities 
(Nelson et al., 2013; Siever & Davis, 2004; Taylor, Calkins, & Gur, 2020). By examining 
individuals considered psychiatrically healthy rather than at CHR, we aimed to decouple HC 
variability from psychopathological states. This objective also underlines the importance of 
finding psychosis biomarkers applicable to the entire psychosis spectrum. If potential 
neurobiological markers show graded changes, then subtle correlations with phenotype 
markers (or interactions thereof) may be expected in the nonclinical part of the spectrum. For 
this purpose, we chose schizotypy, which represents stable personality dimensions, and PLE 
that are putatively transitory in nature.  
In the main effect analyses, UnEx, i.e. positive schizotypy, was a significant estimator of left 
amygdala and subiculum volume decrease. Additionally, left subicular volume was positively 
associated with impulsive nonconformity (ImpNon). The modest internal consistency of 
ImpNon was comparable to previous reports from an online community sample, which also 
suggested that ImpNon does not dilute the classical three-factor model of schizotypy (Polner 
et al., 2019). Our findings support the utility of impulsive nonconformity as a separate psychosis 
phenotypic estimator for brain structural variation. Consistent with previous findings suggesting 
that failure to distinguish between positive and negative schizotypy dimensions could result in 
reduced estimator robustness (Barrantes-Vidal, Gross, et al., 2013; Barrantes-Vidal, 
Lewandowski, & Kwapil, 2010), we found differences in the direction between the regressors 
that reflect the unique explanatory contribution of each schizotypy dimension. PLE score was 
not associated with subfield volumes when included alongside schizotypy, indicating that PLE 
do not explain HC volume variability when accounting for schizotypal traits. The significant 
main effect of the positive dimension is not confirmed by a previous study (Sahakyan et al., 
2020) employing the Multidimensional Schizotypy Scale (MSS; Kwapil, Gross, Silvia, Raulin, 
& Barrantes-Vidal, 2018). This inconsistency may be attributed to differences between 
psychometric instruments that provide three (MSS) or four (O-LIFE) phenotype dimensions 
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entered as model predictors. If the positive O-LIFE dimension reflects the core components of 
psychosis as supported by associations with dopamine regulating gene variants (Grant, 
Gabriel, Kuepper, Wielpuetz, & Hennig, 2014), its impact on hippocampal volume would be 
expectedly higher. Although positive schizotypy did not consistently associate with subfield 
volume, selective effects in the subiculum partially support a sensitivity to endogenous factors 
(Alnæs et al., 2019) that may be featured in positive schizotypy to a higher degree. 
While the main effect of positive schizotypy on left subiculum volume was negative, the 
interaction with PLE was associated with volume increases. In the left CA1, this interaction 
emerged at trend-level significance. Schizotypy with PLE relative to schizotypy without PLE 
may signify a dynamic state within the positive trait dimension. A longitudinal behavioural study 
found that the expression of transient subclinical psychotic features is influenced by time-
invariant traits (Rössler, Hengartner, Ajdacic-Gross, Haker, & Angst, 2013). As schizotypal 
personality organisation bestows an individual with a predisposition for stress response 
(Grattan & Linscott, 2019; Soliman et al., 2011), PLE could indicate an ongoing susceptibility 
to latent states and stressors (Barrantes-Vidal, Chun, et al., 2013; Rössler et al., 2013), genetic 
and environmental influences (Barkhuizen, Pain, Dudbridge, & Ronald, 2020; Brambilla et al., 
2014). Extending this to neurobiological measures demonstrated that the positive relationship 
between PLE and left subicular volume depended on increased positive trait schizotypy. In 
those individuals at higher positive schizotypy driving this effect, levels of disorganised and 
impulsive traits, and more importantly, distress severity were augmented. Increased PLE 
distress severity in high schizotypy is contrary to a previous finding (Kline et al., 2012). Thus, 
a consistent expression of 'benign' or 'happy schizotypy' (Farias, Underwood, & Claridge, 
2013; Grant & Hennig, 2020; Mohr & Claridge, 2015) which could explain the observed positive 
correlation between PLE and schizotypy does not match the phenotype presented in this study.  
We extended the longitudinal HC axis by the inclusion of the amygdala, which, together with 
the subiculum, showed an unexpected negative association with positive schizotypy. A linkage 
between these two regions is supported by substantial inputs to the amygdala from the 
(temporal end of the) CA1, and the subiculum (Pitkänen, Pikkarainen, Nurminen, & Ylinen, 
99 
 
2000), although we did not find the association between positive schizotypy and  CA1 region. 
CA1 volume change may especially demarcate CHR trajectories as it was the only HC subfield 
associated with progressive global symptomatic deterioration in UHR individuals (Ho et al., 
2017). An association between the anterior HC, which includes CA1, and negative schizotypy 
was dependent on high disorganised schizotypy measured by the MSS (Sahakyan et al., 
2020). Still, in alignment with our findings, no main effect of the positive dimension was present. 
This may reflect results from nonclinical individuals displaying persistent PLE, suggesting that 
cognitive deficits may be more relevant for poorer outcomes than positive PLE (Brett, Peters, 
& McGuire, 2015). In UHR individuals, CA1 and subiculum volumes were positively correlated 
with verbal performance (Vargas et al., 2018), and subicular volume was also associated with 
negative symptoms in schizophrenia and cognitive deficits in bipolar disorder (Haukvik et al., 
2015). Examining how cognitive endophenotypes (Siddi, Petretto, & Preti, 2017) relate to 
medial temporal lobe structures (Antoniades et al., 2018) in the nonclinical psychosis spectrum 
may help close a gap in the literature.  
Contrary to expectations, we did not find that amygdala volume is related to negative or 
impulsive trait expressions. Building on previous clinical studies that assessed psychotic 
symptoms using the PANSS (Kawano et al., 2015; Kühn et al., 2012; Mathew et al., 2014), we 
could neither confirm associations between negative schizotypy and CA2/3 or CA4/DG. Other 
studies report functional specialisation in these regions compatible with cognitive impairments 
(Haukvik et al., 2018; Vargas et al., 2018). Tamminga et al. (2012) propose a model in which 
homeostatic plasticity of CA3 in response to reduced glutamate DG signaling may lead to 
psychotic memory impairments. A study of first-episode schizophrenia did not confirm HC 
subfield volume correlations with negative or total PANSS scores, but instead found a positive 
relationship between right CA1 volume and positive PANSS score (Hýža, Kuhn, Češková, 
Ustohal, & Kašpárek, 2016). Across the psychosis continuum, relationships between different 
symptom domains and HC subfields (notably the subiculum) are emerging – especially in the 
nonclinical part– with variable consistency.  
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The main effects of disorganised and negative schizotypy dimensions on subfield volumes 
were insignificant, partially supporting the explanation that high positive schizotypy is the main 
driver. In the light of previous findings demonstrating that prediction of prodromal outcomes 
was explained by additive effects of positive and negative schizotypy (Barrantes-Vidal, Gross, 
et al., 2013), this may suggest that within individuals displaying increased positive schizotypy, 
these proneness profiles are not wholly enough expressed to effect noticeable differences 
across all longitudinal volumes utilised in this study. Consistent with this explanation, 
interactions between positive, negative, and disorganised dimensions reach significance in the 
anterior, but not the posterior portion of the hippocampus (Sahakyan et al., 2020), supporting 
an anterior-posterior gradient of pathological hippocampal volume changes in clinical subjects 
(McHugo et al., 2018). Apart from longitudinal, opposed to anterior/posterior subdivisions, 
usage of different automated segmentation methods may further explain discrepancies among 
studies.  
In this study, HC subfield volume correlates corresponded to psychosis phenotypes absent of 
a clinically manifest vulnerability. Notably, this does not necessitate exemption from 
vulnerability in the form of genotypes associated with PLE and schizotypy (Legge et al., 2019; 
Meller et al., 2019), or hippocampal subfield volumes (Alnæs et al., 2019; van der Meer et al., 
2020). As indicated by moderation, in healthy participants with PLE not indicative of CHR, the 
effect on HC subfield volume was trait schizotypy driven. Lack of association between PLE 
and medial temporal structures over and above the schizotypal traits may be explained by 
comparatively small effect sizes or reduced PLE persistence (Dominguez, Wichers, Lieb, 
Wittchen, & Van Os, 2011; Hanssen, Bak, Bijl, Vollebergh, & Os, 2005; Nelson, Fusar-Poli, & 
Yung, 2012). Since the PQ-16 does not provide a measure of PLE persistence, longitudinal 
investigations are required to address this issue. The present findings imply a sensitivity of the 
limbic structures to time-invariant traits rather than PLE. Furthermore, while considerable 
overlap appears between the positive schizotypy dimension and PLE in both healthy and CHR 
cohorts (Barrantes-Vidal, Gross, et al., 2013), and their relationship with neurobiological 
targets, unusual experiences in the context of positive schizotypy and PLE might not be 
101 
 
interchangeable phenomenological entities. We advocate a phenotype distinction based on 
transience (PLE) and stability (traits) (Pedrero & Debbané, 2017; Seiler, Nguyen, Yung, & 
O’Donoghue, 2020). However, to our best knowledge, no assessment of the discriminant 
validity between positive psychometric schizotypy and PLE so far exists. There was a 
considerable overrepresentation of females and an absence of psychopathology in the present 
cohort, limiting comparability with other studies reporting expectedly higher CHR screening 
rates in the general population (McDonald et al., 2018).  
This study was also the first to use CAT12 automated segmentation for HC subfield 
delineation. This achieves an alternative route to limbic subfield characterisation compared 
anterior and posterior HC subdivisions applied elsewhere (McHugo et al., 2018; Sahakyan et 
al., 2020). Our findings from a novel toolbox call for replication so that results from different 
HC subfield volumetry methods will expectedly accumulate. We provide evidence for an 
association between elevated trait schizotypy and left subiculum volume reductions. This result 
complements the dose-response relationship of left subfield volume reductions in the clinical 
part of the psychosis spectrum (Vargas et al., 2018). Additionally, an interaction between 
psychosis prone traits and transitory PLE may reflect schizotypy dynamics, resulting in medial 
lobe structural variation. Together with previous findings, we propose that future studies 
involving PLE could explore (and control for) variance explained by positive schizotypy, PLE 
distress, or persistence. Aetiological studies involving endophenotypes capturing genetic 
psychosis liability, especially in association with medial lobe structures, could benefit from 
incorporating individual differences.  
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